Health care quality indicators in the Irish health system. Examining the potential of hospital discharge data using the Hospital Inpatient Enquiry System. by unknown
 - i - 
 
Health Care Quality Indicators in the 
Irish Health System 
Examining the Potential of Hospital Discharge Data using the Hospital 
Inpatient Enquiry System 
 
 
 
  
 
 - ii - 
 
 
 
 
 
 
Health Care Quality Indicators in the 
Irish Health System: 
Examining the Potential of Hospital Discharge Data using the 
Hospital Inpatient Enquiry System 
 
 
 
 
 
 
 
 
 
Report prepared by the CMO Office, 
Statistical analysis by the Information Unit, 
Department of Health 
 
 
Special thanks are due to the hospitals who commented on their data to inform this study. 
 
December 2013.  
 
  
 - iii - 
Executive Summary 
 
Purpose of report 
A quality health service provides the range of services which meet the most important health 
needs of its population in a safe and effective way, without waste and within the regulatory 
framework.  
Monitoring the performance of health services in meeting their objectives is important in 
supporting and strengthening accountability and in improving the quality and safety of the 
services. Information, including performance indicators, can be used to monitor and evaluate 
the effectiveness and safety of services, to identify areas of performance which may require 
further exploration and action and to inform decisions about the planning, design and delivery 
of services.    
The purpose of this report is to propose and examine a number of key quality indicators 
derived from Hospital Inpatient Enquiry (HIPE) data in order to assess their feasibility in 
monitoring quality of care and measuring health service performance. The Economic and 
Social Research Institute (ESRI) manages the HIPE system on behalf of the Health Service 
Executive (HSE) and provides support and training to the hospitals and the coders in the 
hospitals.
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Background and methods 
The monitoring of the quality and safety of healthcare is becoming increasingly important 
internationally and many countries use quality indicators to monitor the performance of their 
health services and to highlight issues that need further exploration in relation to quality and 
safety.  
The Organisation for Economic Co-operation and Development (OECD) and other bodies 
internationally have begun to exploit the potential of routine hospital discharge data for the 
purpose of measuring indicators of quality. The OECD Health Care Quality Indicators (HCQI) 
project, which commenced in 2001, shows that high level indicators based on specific 
diagnoses and/or procedures are valuable as a first step in the comparison of performance 
(http://www.oecd.org/health/hcqi). Ireland as part of the OECD has been reporting into this 
project using HIPE data.  
The Hospital Inpatient Enquiry (HIPE) system provides a rich source of data on discharges 
from all publicly funded acute hospitals in Ireland. Originally designed to record hospital 
activity, its functions have expanded over time and now it is a well-developed database used 
for a variety of purposes including case-mix based hospital funding. It is also proposed that 
HIPE will have a key role in future health reforms including “Money follows the Patient” and 
Universal Health Insurance. 
In line with other countries it was decided that potential candidates for quality indicators 
should be identified and assessed as a precursor to the development of specific quality and 
safety indicators for the Irish health system. The study builds on the work of the OECD with 
many of the indicators examined based on the definitions and guidelines set out by the OECD 
as part of the HCQI project. A number of additional indicators were also developed based on 
further research and discussion between relevant experts and clinicians.  
One of the key factors in assessing the feasibility of indicators is the availability of and access 
to a comprehensive quality information system. As HIPE is a publicly funded major source of 
information on acute hospital activity in Ireland this report assesses the feasibility of indicators 
derived from HIPE.  
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 During the process of compiling this report, the HIPE system was administered by the Health Research and 
Information Division in the ESRI. From 1
st
 January 2014 responsibility has been transferred to the Healthcare Pricing 
Office within the Health Service Executive.  
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Other criteria considered in this analysis of feasibility of the selected indicators included: 
 Are there agreed international definitions and guidelines for the indicator?  
 Is there potential for international comparability? 
 Are all of the necessary variables currently coded in HIPE? 
 Are there sufficient numbers of cases (both numerator and denominator) with 
identified conditions to support the calculation of rates?  
 Are there ICD-10-AM codes available for the conditions assessed? 
 Are there sources apart from HIPE available that are more accessible and robust? 
 Are the indicators representative of a range of process, structure and outcome 
indicators? 
Since this was a preliminary scoping study the analysis was high level focusing on the 
principal diagnosis or procedures
2
.  
The preliminary focus of this study was to assess the feasibility of indicators derived from 
HIPE. As part of this study an analysis of the data for the selected indicators was undertaken 
with a process for referral to the HSE Quality and Patient Safety Directorate if issues were 
highlighted that required further exploration and possible action.  
 
Summary of the indicators considered for selection 
See Appendix 1 for detailed indicator specifications.  
Selected indicators: 
 In-hospital mortality within 30 days after acute myocardial infarction (AMI) 
This indicator is defined as the number of patients who die in hospital within 30 days 
of being admitted to hospital with an AMI as a proportion of the total number of 
patients admitted to that hospital with an AMI. Both crude mortality rates and age-
standardised mortality ratios were calculated, aggregated over the period 2008-2010. 
This is an OECD indicator.   
 In-hospital mortality within 30 days after ischaemic stroke 
This indicator is defined as the number of patients who die in hospital within 30 days 
of being admitted to hospital with ischaemic stroke as a proportion of the total number 
of patients admitted to that hospital with ischaemic stroke. Both crude mortality rates 
and age-standardised mortality ratios were calculated, aggregated over the period 
2008-2010. This is an OECD indicator.   
 In-hospital mortality within 30 days after haemorrhagic stroke 
This indicator is defined as the number of patients who die in hospital within 30 days 
of being admitted to hospital with haemorrhagic stroke as a proportion of the total 
number of patients admitted to that hospital with haemorrhagic stroke. Both crude 
mortality rates and age-standardised mortality ratios were calculated, aggregated 
over the period 2008-2010. This is an OECD indicator.   
 In-hospital mortality within 30 days following hip fracture surgery 
This indicator is defined as the number of patients undergoing hip fracture surgery 
who die in hospital within 30 days of admission as a proportion of the total number of 
patients who underwent hip fracture surgery. Both crude rates and age-standardised 
mortality ratios were calculated, aggregated over the period 2006-2010. This is not an 
OECD indicator.   
 In-hospital mortality within 30 days after colectomy for emergency admissions 
This indicator is defined as the number of patients undergoing colectomy surgery and 
admitted as an emergency who die in hospital within 30 days of admission as a 
proportion of the total number of emergency admissions who underwent a colectomy. 
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Both crude mortality rates and age-standardised mortality ratios were calculated, 
aggregated over the period 2006– 2010.  This is not an OECD indicator.   
 Time to hip fracture surgery  
This indicator is defined as the time from admission of a person aged 65 years or 
older with a principal diagnosis of fractured neck of femur to time of surgery for the 
fracture aggregated over the period 2008-2010. This is an OECD indicator.  
 Age at orchidopexy 
This indicator is defined as age at which orchidopexy is undertaken for the treatment 
of undescended testes, aggregated over the period 2006-2010. This is not an OECD 
indicator. 
Other indicators considered: 
 Age at first hospital admission with developmental dysplasia of hip (DDH). 
 Rate of pulmonary embolism (PE) or deep vein thrombosis (DVT) following surgery.   
 Rate of catheter-related blood stream infections.  
 Proportion of patients with ST elevation myocardial infarction (STEMI) who received 
thrombolysis or cardiac catheterisation within the following 24 hours. 
 Number of falls in hospitals as a percentage of all inpatient discharges. 
 Rate of ventilator associated pneumonia (VAP). 
 
Many of the high level indicators presented in this report are based on definitions developed 
in the context of the OECD HCQI project. Where relevant, and in line with OECD guidelines, 
the indicators have been age-standardised to take account of differences in the age profiles of 
patients across hospitals.  In-hospital mortality rates are considered by the OECD and other 
international agencies to be useful indicators of hospital care (AHRQ, 2013).  These are high-
level measures, the benefit of which is that they provide for a standard international approach, 
which allows for cross-country comparisons.  However, there is an inevitable trade-off with the 
precision of the indicators, particularly the lack of inclusion of co-morbidities and other 
confounding factors.  
The 30 day in-hospital mortality indicators after AMI, stroke, colectomy and hip fracture are 
calculated based on deaths in hospital after admission with the relevant principal diagnosis or 
procedure. The indicator does not attribute the mortality to that principal diagnosis or 
procedure. For example, it is likely that many deaths following hip fracture are due to medical 
complications rather than hip fracture surgery itself.   
 
Findings 
The study found that a number of the selected indicators derived from HIPE fulfilled most if 
not all of the criteria in order to be considered feasible. However it also found that some of the 
other indicators reviewed would require significant changes to the indicator definitions and 
methodology, and/or to the data in the HIPE system to be considered as fulfilling the 
feasibility criteria.  
The indicators considered as feasible are set out below, although it is also recognised that for 
each of these indicators there were some issues of quality and robustness that should be 
explored and if possible addressed through further development.  
The preliminary assessment of in-hospital mortality within 30 days after acute myocardial 
infarction (AMI) and ischaemic and haemorrhagic stroke provided the following findings: 
 Preliminary assessment of the indicator for in-hospital mortality within 30 days after 
admission for AMI as derived from HIPE suggests that it meets the criteria for 
feasibility as a potentially useful indicator although limitations were also highlighted. 
 The indicators on in-hospital mortality within 30 days following ischaemic and 
haemorrhagic stroke also show that it is feasible to use these indicators as derived 
from HIPE, although again there were a number of significant limitations.  
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Some of the limitations highlighted in relation to these three mortality indicators included that 
the indicators do not attribute the mortality to the principal diagnosis or procedure. Also this 
preliminary analysis did not assess and take into account patient factors including co-
morbidities and medication use that may have an effect on the outcomes. It is suggested that 
a more developed analysis that takes into account these factors would lead to improvement in 
these measures. 
Furthermore, 30-day in-hospital mortality rates are also influenced by factors occurring before 
or after treatment in hospital. This includes access and care prior to reaching hospital, within 
the emergency department or following discharge from hospital. In Ireland it is also not 
possible at present to track deaths which occur outside hospital within the 30-day period. 
The development of systems to capture this data would improve the measure. However, in-
hospital mortality rates, while they must be interpreted with caution, are useful in identifying 
variation that should be explored further. 
For some in-hospital mortality indicators, the age-standardised mortality ratios were higher 
than expected in a small number of hospitals during the period of analysis.
3
 The Quality and 
Patient Safety Directorate of the HSE and the individual hospitals were communicated with 
about these variations. As a result, a number of hospitals on reviewing their healthcare 
records and HIPE data found inconsistencies in the recording in medical records and/or in 
coding into the HIPE system. It is important to note that the issues of data quality referenced 
in the study relate to the small number of hospitals which reviewed their data. 
Preliminary assessment of the indicator on in-hospital mortality following hip fracture surgery 
as derived from HIPE suggests that it offers good potential as an outcome measure. 
However, it must be noted that due to small numbers in the Irish system in some hospitals the 
likelihood of observation of statistically significant variation is reduced, even where that 
variation may be important clinically.  
Also for this indicator patient factors including co-morbidities are likely to affect mortality rates. 
Therefore a more developed analysis that accounts for these issues could improve this 
measure. It is also important to note that mortality following hip fracture is generally due to a 
medical condition and therefore medical care and the provision of an ortho-geriatric service 
may affect variation in outcomes following hip fractures. As stated before 30-day mortality in- 
hospital rates are likely to be affected by factors that occur before or after treatment within the 
hospital.   
Preliminary assessment of the indicator on the in-hospital mortality rate following emergency 
admission and colectomy surgery suggests that it offers good potential as a future outcome 
measure. Although the small numbers for this condition could present an issue leading to 
unstable and unreliable rates, this can be counterbalanced by the likelihood that for this 
indicator the recording of death and procedure are more likely to be accurate. Again, taking 
into account patient factors such as co-morbidities could improve this indicator. 
The indicator on time to hip fracture surgery is used internationally as a measure of quality. In 
this study it was found that this indicator is useful as a high level indicator but has a significant 
limitation, in that time data was not captured in HIPE prior to 2011. It is proposed that to 
improve this indicator accurate time of admission and times of procedures should be recorded 
on HIPE. Since 2011 times of admission and discharge are being recorded on HIPE, although 
times of procedures are not at this point available. 
Review and analysis of the indicator on age at orchidopexy showed that this indicator derived 
from HIPE is feasible and has potential as an outcome measure. However the analysis 
highlighted some issues with this indicator including information on whether a delay in 
admission for orchidopexy was due to lack of timely diagnosis or access issues. HIPE does 
not cover outpatients, community or primary care and therefore cannot provide information on 
the care provided in these settings including access to screening and appropriate referral.  
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However the study has shown that this indicator can be derived from HIPE due to the clear 
recording of a treatment specific procedure and age at admission for this procedure. It 
therefore highlights the need for further exploration to determine the reasons for variations in 
findings. 
Other indicators reviewed included age at first hospital admission with developmental 
dysplasia of hip (DDH). The review indicated that it is not feasible to derive a robust indicator 
for management of DDH from HIPE for many reasons including small numbers and whether it 
is an accurate reflection of the diagnosis and management of DDH. 
Other indicators were also reviewed but were not considered feasible for a number of reasons 
including lack of a specific ICD-10-AM code for the condition in HIPE or small numbers for 
specific conditions. These indicators are more fully discussed in the text of the report. 
As previously stated initial analysis found that a small number of hospitals reported 30-day 
mortality rates higher than would be expected when compared with national rates. While it 
was known to be likely that inconsistencies in reporting and other factors could account for 
some of this variation, it signalled that further exploration and explanation was required 
particularly to rule out patient safety issues. Therefore, the HSE was advised where there was 
significant variation from the national average in a hospital or region and that these findings 
required further exploration and explanation. The Quality and Patient Safety Directorate of the 
HSE followed up by communicating with the individual hospitals and providing the relevant 
data to hospitals in order for them to comment on the quality of their data and to ensure that 
there were no patient safety issues.  
In response these hospitals undertook a further review, the extent and method of which varied 
by hospital. The majority of hospitals which undertook a review examined the healthcare 
records and HIPE records of patients who died following admission with the principal 
diagnosis (primary reason for admission) under investigation. The hospitals identified a 
number of issues in relation to their data, including incorrect recording of the principal 
diagnosis in the healthcare record and, to a lesser extent, incorrect coding from the 
healthcare record into the HIPE system. Their reviews highlighted issues in relation to data 
quality. The learning from the hospitals’ reviews of their data was very valuable and is 
therefore included in the text of this report. It is important to note that the purpose of this 
report was not to assess the overall quality of HIPE data, although the reviews carried out by 
some hospitals indicated data quality issues that should be further examined and addressed.  
The further refinement and development of these indicators should include assessments of 
the quality of healthcare records and the associated HIPE data, including issues such as the 
application of coding guidelines, the depth of coding of comorbidities and other factors such 
as transfer status.  
The HIPE files for the years 2005 to 2010 for all hospitals were reopened on a phased basis 
starting from the end of 2011. Some hospitals, including some of the hospitals which reviewed 
their data following the initial findings, made changes to their HIPE files. The revised HIPE 
files are now included in this report. The findings, analysis and discussion in this report are 
based on the initial data and the revised HIPE data resubmitted by hospitals. However it 
should be noted that not all hospitals resubmitted data following the reopening of the HIPE 
files. This can raise issues in relation to interpretation as some hospitals made changes to 
their HIPE data but not all hospitals did and some hospitals only focused on certain conditions 
and related deaths. Some of these issues could be addressed through a review of all 
healthcare records to check the accuracy of the principal diagnosis. However the primary 
focus of this study was to look at the feasibility of these indicators and to progress to robust 
indicators for the future rather than carrying out a review of historical data.  
  
 - viii - 
Conclusions 
Internationally the use of quality indicators to measure health service performance is 
recognised as an important initiative in improving the quality, effectiveness and safety of 
healthcare. In line with this approach and building on the work of the OECD through the 
Health Care Quality Indicators (HCQI) initiative, the Department established this study as an 
important first step in assessing the feasibility of indicators derived from HIPE as potential 
indicators to be used by the Irish health system to measure health service performance in 
delivering quality healthcare.  
The report highlights important issues in a number of areas including the importance of data 
quality in developing and implementing indicators. Its focus is on the value of HIPE, on the 
importance of data quality and on the benefit to the health system of good quality data. For 
this reason individual hospitals are not identified in this report. 
This report confirms the value of the HIPE system as a resource for the development of 
indicators of quality of care in hospitals in Ireland. At the same time it draws attention to areas 
where HIPE may not be suitable and/or where additions and improvements to HIPE will be 
required prior to using these measures as reliable outcome indicators. The report also 
highlights the requirement for hospitals, with guidance from the HSE, to improve the quality 
and accuracy of the information that they record, both in the healthcare record and 
subsequently onto the HIPE system. It is also the case that in the context of the health reform 
programme the quality of HIPE data is becoming ever more important since the 
implementation of policies such as “Money follow the Patient” and Universal Health Insurance 
require the use of Diagnosis Related Groups (DRGs) which are based on HIPE. 
The preliminary analysis undertaken as part of this study has highlighted factors that may 
have a confounding effect on the findings, particularly in relation to the in-hospital mortality 
indicators. One of the most significant risk factors that affects mortality is age, as the number 
and severity of co-morbidities usually increases with age. The in-hospital mortality indicators 
have been age-standardised as part of the methodology used in this study in order to adjust 
for varying age profiles of patients in different hospitals. However, other confounding factors 
such as co-morbidities, which may influence outcomes, need to be addressed through 
subsequent refinements of the methodology including the addition of further variables in the 
analysis.  
The analysis of hospital level data has highlighted the limitation of small or very small 
numbers when developing and reporting indicators. Small numbers can result in unstable and 
unreliable rates and problems with confidentiality. There are ways to try and counteract this 
for example by aggregating years, by grouping hospitals, or combining clinical groups. This 
report has attempted to address some of these issues through the aggregation of several 
years of data and the inclusion of 95% confidence levels. 
Analysis of the effect of the presence of co-morbidities and other confounding variables such 
as social deprivation would be an obvious next step in any further analysis of these indicators. 
However it would also be very beneficial if a further assessment and implementation of 
identified improvements to data quality was carried out in advance of this process. It should 
also be noted that the introduction of a unique patient identifier would greatly assist in 
developing accurate and robust indicators. Linking to other datasets, such as Central 
Statistics Office mortality data also has the potential to improve these indicators. 
This study has shown that some of the data used in the calculation of these indicators was 
unreliable due to lack of consistency in the documentation in the healthcare record and 
subsequently the transfer onto the HIPE system. However this is data entered directly by the 
hospitals and therefore the quality of the healthcare record and the inputted data is the 
responsibility of the hospital. This data is an important source of information for the hospitals, 
for the health system and also for the public. Indicators derived from data entered by the 
hospital onto HIPE allow hospitals to monitor their own performance over time. This ability to 
compare outcomes over time and across services is an important function and it is essential 
for service providers to have high quality information available to them that allows them to do 
this.  
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The observed variations across hospitals found in this study may be due to a number of 
factors, including quality of care issues, data quality issues or issues in relation to the 
inclusion of confounding factors in the analysis. The small number of reviews carried out by 
hospitals identified issues in regard to the quality of the data, and in particular the medical 
record, which need to be addressed in order to support further analysis and more targeted 
interpretation of results. Nevertheless, the report has demonstrated the value of calculating 
quality indicators based on HIPE data and has identified areas requiring further exploration 
both in relation to data collection and clinical care. 
It is accepted that indicators are alerts or flags to identify areas of performance that may 
require further exploration. In addition indicators can help to identify good practice which can 
then be disseminated throughout the system. However it must be noted that the international 
literature on performance indicators warns against using a specific measure as a generic 
indicator of an organisation’s performance and safety and also highlights the limitations of the 
precise interpretation of the correlation between in-hospital mortality rates and hospital 
performance (Health Foundation, 2013). Indicators should be assessed within the context in 
which care is delivered and should not be reviewed in isolation. 
It is important that a range of robust indicators are used to reflect quality of healthcare. The 
findings set out in this report should not be taken as making any inferences concerning quality 
of care in hospitals and certainly should not be interpreted as ranking hospitals with respect to 
the selected indicators.   
Quality indicators should be used by clinical and management teams to monitor the quality of 
care delivered. Following further exploration, and if required, a quality improvement plan that 
can be monitored and evaluated over time should be put in place and systematically 
implemented. 
This report provides a preliminary analysis of indicators derived from reported HIPE data, 
which serves principally to highlight the potential of the selected indicators but also raises 
important questions. This study will inform the future development of healthcare quality 
indicators for Ireland which, aligned with international evidence-based practice,  should then 
be implemented and reported on at all levels of the Irish health system and internationally. 
 
Developments following preliminary findings 
The initial analysis was shared with a number of key agencies including the Quality and 
Patient Safety Directorate (QPS Directorate) of the Health Service Executive (HSE), the 
Health Research and Information Division of the Economic and Social Research Institute 
(ESRI) and the Health Information and Quality Authority (HIQA). All of these agencies 
provided comments on the draft document and these comments have been taken into 
account in the final report.  
As stated previously the QPS Directorate of the HSE contacted and followed up with a small 
number of individual hospitals to further explore specific issues highlighted by the initial 
analysis including mortality rates higher than would be expected when compared with national 
rates.  
The QPS Directorate in conjunction with the office of the Chief Medical Officer (CMO) also 
communicated in January 2012 with all HSE hospitals to state that each hospital should 
review the quality of their data with a particular focus on data for 2011. This communication 
also stated that the data for 2011 would be published in the future with individual hospitals 
identified. 
The Health Intelligence Unit of the HSE in conjunction with the QPS Directorate commenced 
a project to further develop the identified indicators in this study specifically the 30 day in-
hospital mortality rates. This further development of indicators included linking this information 
to data from other databases, for example the CSO mortality data.   
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The Health Research and Information Division in the ESRI have undertaken a number of 
quality initiatives including seminars with a focus on data quality tools.  
HIQA has produced guidance in relation to performance indicators for healthcare:  
“Guidelines on developing Key Performance Indicators and Minimum Datasets to monitor 
healthcare quality” with an update published in February 2013.  
As stated above these initiatives have addressed some of the initial findings from this analysis 
and have progressed the preliminary work undertaken in this study. These initiatives will 
support the development of robust indicators derived from HIPE that can be used by the 
health system, both internally by service providers and by external agencies e.g. regulators 
such as HIQA, to monitor the quality and safety of healthcare while supporting accountability 
and driving improvements in healthcare. Also importantly with public reporting of this 
information the public and policy makers can make informed decisions about their own care 
and future healthcare services. The dissemination of this information should be seen as an 
important driver of improvements in the quality and safety of healthcare in Ireland for the 
future.  
 
Response to the report 
The Hospital Inpatient Enquiry System (HIPE), within certain parameters, will be used by the 
Department of Health (DoH), the Health Service Executive (HSE) and other relevant health 
service providers, to derive performance indicators to measure the performance of health 
services in delivering quality and safe healthcare. These parameters include that the data in 
HIPE is validated, accurate high quality data. 
Clear governance mechanisms at both a national, regional and local level for the quality of 
HIPE will be established including a national governance group and clear service level 
agreements with service providers. Those responsible for the quality of HIPE both at the 
national level, that is the HSE and at a local level, for example acute hospitals, should ensure 
continuous improvement in the quality of HIPE through implementation of quality 
improvement programmes. These quality improvement programmes should include regular 
audits along the data flow pathway and education and training programmes for clinical staff 
and administrative staff involved in HIPE. Under these governance arrangements and as part 
of the annual review process of HIPE variables, specific additions will be considered which 
would enhance the value of HIPE for measuring performance.   
The Department of Health will develop a formal public national reporting system by the 
Minister for Health in relation to National Healthcare System Quality Performance Indicators 
for Ireland. These performance indicators and targets will be aligned with evidence-based 
international practice and linked to international norms, e.g. OECD Health Care Quality 
Indicators, wherever possible. The DoH in establishing the reporting mechanism for National 
Healthcare System Performance Quality Indicators will engage with all key stakeholders 
including the HSE and HIQA.  
The indicators which were assessed to be feasible in this report will be further developed and 
evaluated by the DoH and the HSE in consultation with key stakeholders. The DoH, the HSE 
and the wider healthcare system will also continue to develop and report evidence-based 
quality of care and outcome indicators in line with each organisation’s mandate.  
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Aim and Objectives 
 
The aim of this report is to propose and examine a number of key quality indicators using Hospital 
Inpatient Enquiry (HIPE) data in order to assess their feasibility in monitoring quality of care and 
measuring health service performance. This report is a preliminary study and it is envisaged that the 
findings will inform further exploration and development of indicators to measure the quality of care 
provided by Irish health services. 
The objectives are:  
 To identify selected indicators derived from HIPE data to measure and monitor the quality of 
patient care.  
 To base these indicators, where feasible, on standard international indicators and, in 
particular, on quality of care measures developed by the OECD’s Health Care Quality 
Indicators (HCQI) project. 
 To calculate the indicator data by hospital or region. 
 To examine the data in order to identify its potential and reliability in measuring patient 
outcomes.   
 To examine the indicators and discuss their validity in measuring patient outcomes. 
 To make recommendations in relation to the future potential and methods of improving the 
robustness of indicators derived from HIPE.  
 
Background 
 
A quality health service provides the range of services which meet the most important health needs of 
the population (including preventative services) in a safe and effective way, without waste and within 
the regulatory framework.  
To be able to sustainably deliver quality care, health services need to monitor the quality of the care 
they deliver, the outcomes for their patients and to implement continuous improvements. 
Improvement in the quality of patient care requires a comprehensive, multifaceted approach to 
identifying and disseminating the learning from good quality care and from identifying and managing 
poor quality care in individual services and finding broad long-term solutions for the system as a 
whole. 
A major element of programmes to improve the quality of patient care is the capacity to capture 
comprehensive information including performance measures. Performance measurement enables 
informed decision making by monitoring, analysing, and communicating the degree to which key 
organisational goals are met.  Performance measures, such as indicators, can also be used to identify 
areas of performance which may require further exploration and sometimes immediate action. 
However, it is internationally recognised that it is important that when measuring performance a 
balance of measurements is used and that there is no single measure that provides assurance of an 
organisation’s safety or quality of performance. Therefore it is important that a range of indicators are 
used that reflect structure, process and outcomes.   
Performance measurement contributes to improving quality in a number of ways. Firstly, it drives 
improvement by enabling service users to make choices based on quality measures, which in turn 
creates an incentive for providers to improve performance so as to attract more service users.  
Secondly, professionals have an intrinsic desire to improve performance when they are made aware, 
through performance measurement, that there is potential for improvement. Thirdly, performance 
measurement drives improvement through comparing the performance of individuals, teams or 
organisations resulting in a desire to improve or maintain performance relative to others and the 
reliability of the quality and safety of services that they provide. 
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In choosing key quality indicators it is important that  
• they can be measured 
• measurement can be realistically achieved within available resources 
• they are important to patient safety and patient care 
• they are valid indicators of performance 
• they contribute to service improvement and cost efficiencies 
• they are actionable  
• they have intelligent targets.   
 
Indicators should also be chosen that enable international performance comparisons, where possible.  
They should take cognisance of the important factors for key performance indicators as outlined in the 
Health Information and Quality Authority’s (HIQA),  Guidelines on Developing of Key Performance 
Indicators and Minimum Data Sets to Monitor Healthcare Quality (available at 
http://www.hiqa.ie/resource-centre/professionals/kpi-data-sets). 
Performance measurement is a continuous process that involves collecting data to determine if a 
service is meeting desired standards or targets. It is dependent on good quality information on health 
and social care which can only be achieved by having a systematic process to ensure that data are 
collected consistently, both within, and across organisations. Development of de novo systems to 
measure quality outcomes would likely ensure the most robust indicators but would be very costly and 
resource intensive. Utilisation of existing data sources, therefore, may provide a useful alternative. 
There are a number of data systems within the Irish health and social care system that may be fit for 
this purpose including the Hospital In-Patient Enquiry (HIPE) system.   
This study examines the feasibility of developing and measuring a number of quality of care indicators 
based on data from the HIPE system. HIPE is a computer-based system designed to collect patient 
demographic, clinical and administrative data on discharges and deaths from acute hospitals 
nationally. All acute public hospitals participate in HIPE reporting on over 1.4 million discharges in 
2010. The Economic and Social Research Institute (ESRI) manages the HIPE system on behalf of the 
Health Service Executive (HSE) and provides support and training to the hospitals and the coders in 
the hospitals.
4
 
While HIPE was originally designed to measure hospital activity rather than to assess hospital 
performance, it provides a rich source of data with the potential to shed light on issues of quality of 
care.  
Doctors, nurses, and other healthcare professionals input information into the healthcare record. The 
HIPE coding team in the hospital is then responsible for accurately transferring information from the 
healthcare record to the HIPE system. This information is then exported to the ESRI, where additional 
validation checks are carried out prior to the data being used for reporting and analysis. It should be 
noted that validation at this point cannot identify cases where the information may be inaccurate but, 
nevertheless, coded appropriately.  
The ESRI, HSE and Department of Health (DoH) utilise the national HIPE database to monitor many 
aspects of the health service. To date, most of this monitoring has been on types and levels of activity 
and on costing through the application of case-mix modelling to the HIPE data. However many bodies 
including the HSE through the Health Intelligence Unit and the clinical programmes have begun to 
recognise and exploit the potential of HIPE and other administrative data sets in supporting and 
enabling measurement of quality of care.     
For the purposes of this study, a number of indicators have been selected to assess the potential of 
deriving quality of care indicators from HIPE. The study mainly focuses on the feasibility of deriving 
these indicators from HIPE, rather than on other possible selection criteria. However it should be 
noted that most of the selected indicators are based on indicators used internationally to measure 
quality of care. In fact where available, these indicators are based on the rigorous developmental 
work carried out by the OECD as part of its Health Care Quality Indicators (HCQI) project. This project 
continues to demonstrate clear value in the use of routine hospital discharge data for the purposes of 
                                               
4
 During the process of compiling this report, the HIPE system was administered by the Health Research and Information 
Division in the ESRI. From 1
st
 January 2014 responsibility has been transferred to the Healthcare Pricing Office within the 
Health Service Executive.  
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performance measurement and for cross-country comparisons. Ireland is involved in the OECD HCQI 
project and Irish data is being published as part of the OECD reports. There are four OECD indicators 
that have been selected for this study.  
A number of other indicators were selected for assessment based on consideration by relevant 
experts and clinicians of their feasibility, validity and balance (structure, process and outcome). Two 
of these indicators are based on mortality following surgery. The international literature suggests that 
mortality following surgery varies with individual surgeons, teams, hospitals and services and that this 
variation is influenced by a number of factors including procedure volume and access to effective 
multidisciplinary care (Birkmeyer, JD and Dimick, JB, 2009).    
The HIPE system does not cover community or primary care and in the absence of this it was 
proposed that indicators would be selected for assessment that may reflect some aspects of 
community and primary care. Therefore two indicators were chosen to review: age at which 
orchidopexy is undertaken for the treatment of undescended testes and age at first admission to 
hospital with a principal diagnosis of developmental dysplasia of hip (DDH).  
The suite of indicators presented does not purport to provide a comprehensive or representative view 
of areas where measurement of the quality of care is indicated, but rather aims to assess the 
feasibility of these selected indicators as derived from HIPE.   
The main criteria considered in this analysis of the feasibility of these selected indicators derived from 
HIPE included whether: 
 There are agreed international definitions and guidelines for the indicator, for example OECD 
indicators for in-hospital mortality rates for AMI, ischaemic stroke, haemorrhagic stroke.  
 There is potential for international comparability, for example if there are international 
definitions can these be applied to HIPE data and whether the coding system facilitates cross-
country comparisons i.e. use of ICD-10-AM.   
 International data are available on the indicators to allow comparison. 
 All of the necessary variables are currently collected in HIPE and could any additional 
variables be included in HIPE that may improve the reliability of an indicator. 
 There are sufficient numbers of cases (both numerator and denominator) to support the 
calculation of rates.  
 There are specific ICD-10-AM codes available for the conditions assessed. 
 There are sources apart from HIPE available that are more accessible and robust. 
 Whether the indicators are representative of a range of process, structure and outcome 
indicators.  
 
This report examines high level indicators, which are defined not as direct measures of quality but 
rather as indicators which can be used to draw attention to issues that may need further exploration or 
action. It should be emphasised that this report does not subscribe causal explanations to any 
observed variations in the selected indicators. Any variations highlighted require, as with any 
variations in indicator outcomes, further exploration to elucidate underlying causes, for example in this 
instance in relation to quality of data, quality of clinical care, and the relative effects of other factors 
influencing outcomes.  
The indicators in this paper focus on: 
1. 30 day in-hospital mortality.  
2. Time to surgery for hip fracture.   
3. Age at hospital admission for treatment of undescended testes in childhood.  
The methodology section below describes both the indicators and the process of analysis undertaken 
for this report. It also highlights some of the limitations inherent in the approach including issues of 
data quality and the absence of a unique identifier. The concluding section of the report discusses the 
interpretation of the results and, given that this work should be seen as the preliminary stage of a 
process, makes recommendations for improving the validity and robustness of these indicators 
derived from HIPE.   
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Methodology 
 
This study involved the selection of a number of indicators derived from HIPE for assessment. Their 
selection was primarily informed by the indicators developed as part of the OECD Health Care Quality 
Indicators project and also from discussions with relevant experts and clinicians. 
The assessment of the indicators included analysis of data derived from the HIPE system on both day 
cases and inpatients discharged from public hospitals in Ireland over a three to five year period to 
2010.  
HIPE data are coded for each patient discharged within each hospital. The data are episode-based 
rather than patient-based. A full description of HIPE and the definition of terms used by the HIPE 
system (diagnoses, procedures etc.) can be found at www.HIPE.ie. 
Initially the final 2010 HIPE file, version December 2011, was used for the analysis. For this analysis it 
was found that for most hospitals in the study coverage was in excess of 99% complete for 2010 
HIPE data. One hospital did not code for a 4-month period in 2010 but the coverage for the rest of the 
year was sufficient to include this hospital. However this results in a smaller number of cases which is 
reflected by wider confidence intervals. As there is complete data for this hospital up to August 2010, 
the issue of selection bias does not arise. Another hospital has been included in HIPE since 2009 but 
only had complete data for one year and therefore was not included in this study. A small number of 
non-acute hospitals, which report to HIPE, were also excluded from the analysis.   
Paediatric hospitals were included in only two indicators: age at hospital admission for treatment of 
developmental dysplasia of the hip (DDH) and age at orchidopexy for treatment of undescended 
testes.   
The in-hospital mortality indicators for acute myocardial infarction (AMI) and stroke are based on the 
principal diagnosis. This is defined as the diagnosis established after study to be chiefly responsible 
for occasioning an episode of admitted patient care. It should be noted that the principal diagnosis 
may not be the cause of death. 
For these mortality indicators data were examined by individual year and in many cases the numbers 
were found to be too small to allow the calculation of meaningful rates for individual hospitals.  
Therefore, the indicators were calculated with data aggregated over 3 years, and in some cases 5 
years, to ensure sufficient numbers for the calculation of rates.   
In order to control for the effect of age on death rates, age standardisation was carried out. Age-
standardised mortality ratios (SMRs) were calculated for all of the in-hospital mortality indicators. 
SMRs show whether more deaths than expected (SMR>100) or fewer deaths than expected (SMR 
<100) occurred if the study population (i.e. the admitted patients with the relevant diagnosis or 
procedure in each hospital) experienced the same age-specific mortality as the general population 
(i.e. the total admitted patients nationally with the relevant diagnosis or procedure during the chosen 
time period). Upper and lower 95% confidence intervals for SMRs were also calculated.
5
   
Note that the purpose of SMRs is to compare the rates for hospitals with the national rate only. SMRs 
cannot be used to compare one hospital with another, as the age structure of each hospital weights 
the age-specific rates differently. 
While the HIPE system collects data on secondary diagnoses (i.e. co-morbidities), medical card 
status (which can be considered a proxy for socio-economic status), and admission and discharge 
types including transfer status, these factors were not included in this report’s analysis as this was a 
preliminary high level study to determine the feasibility of HIPE as a source for these indicators.  The 
inclusion of these additional confounding variables should be a further stage in the process of 
development and refinement of performance indicators based on HIPE.  
 
                                               
5
 See Appendix 3 for the age-standardisation methodology. 
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Selected indicators: 
 
 In-hospital mortality within 30 days after acute myocardial infarction (AMI) 
This indicator is defined as the number of patients who die in hospital within 30 days of being 
admitted to hospital with an AMI as a proportion of the total number of patients admitted to 
that hospital with an AMI.  Both crude mortality rates and age-standardised mortality ratios 
were calculated and presented by hospital, aggregated over the three-year period 2008 to 
2010. This is an OECD indicator.   
 In-hospital mortality within 30 days after ischaemic stroke 
This indicator is defined as the number of patients who die in hospital within 30 days of being 
admitted to hospital with ischaemic stroke as a proportion of the total number of patients 
admitted to that hospital with ischaemic stroke. Both crude mortality rates and age-
standardised mortality ratios were calculated and presented by hospital, aggregated over the 
three-year period 2008 to 2010. This is an OECD indicator.   
 In-hospital mortality within 30 days after haemorrhagic stroke 
This indicator is defined as the number of patients who die in hospital within 30 days of being 
admitted to hospital with haemorrhagic stroke as a proportion of the total number of patients 
admitted to that hospital with haemorrhagic stroke. Both crude mortality rates and age-
standardised mortality ratios were calculated and presented by hospital, aggregated over the 
three-year period 2008 to 2010. This is an OECD indicator.   
 In-hospital mortality within 30 days following hip fracture surgery 
This indicator is defined as the number of patients undergoing hip fracture surgery who die in 
hospital within 30 days of admission as a proportion of the total number of patients who 
underwent hip fracture surgery. Both crude mortality rates and age-standardised mortality 
ratios were calculated and presented by hospital, aggregated over the five-year period 2006 
to 2010. This is not an OECD indicator.   
 In-hospital mortality within 30 days after colectomy for emergency admissions 
This indicator is defined as the number of patients undergoing colectomy surgery and 
admitted as an emergency who die in hospital within 30 days of admission as a proportion of 
the total number of emergency admissions who underwent a colectomy. Both crude mortality 
rates and age-standardised mortality ratios were calculated and presented by hospital, 
aggregated over the five-year period 2006 to 2010. This is not an OECD indicator.   
 Time to hip fracture surgery  
This indicator is defined as the time from admission of a person 65 years or older with a 
principal diagnosis of fractured neck of femur to time of surgery for the fracture aggregated 
over the period 2008-2010. This is an OECD indicator.  
 Age at orchidopexy 
This indicator is defined as age at which orchidopexy is undertaken for the treatment of 
undescended testes. This is reported as number and proportion of cases by age group and 
HSE region of residence over the five-year period 2006 to 2010.  This is not an OECD 
indicator. 
 
Other indicators considered: 
 Age at first hospital admission with developmental dysplasia of hip (DDH) was calculated from 
age at first admission to hospital with a principal diagnosis of DDH.  This is not an OECD 
indicator.   
 Rate of postoperative pulmonary embolism (PE) or deep vein thrombosis (DVT). This is an 
OECD indicator.  
 Rate of catheter related blood stream infections. This was an OECD indicator. 
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 Number and percentage of patients with ST elevated myocardial infarction who received 
thrombolysis or cardiac catheterisation within the following 24 hours. This is not an OECD 
indicator. 
 Number of falls in hospitals as a percentage of all inpatient discharges. This is not an OECD 
indicator. 
 Rate of ventilator associated pneumonia (VAP). This is not an OECD indicator. 
 
For a full description of the selected indicator definitions see Appendix 1. The reasons for the non-
inclusion of the other indicators under consideration are set out in the next chapter. Note that hospital 
names are not included in this report. The data in each table has been sorted by the highest number 
of cases, and the hospitals have been numbered accordingly with the same hospital number used in 
the associated graphs. Hospitals have been numbered for each indicator separately, and so for 
example, hospital 1 in one table is not necessarily the same hospital as hospital 1 in a different table.  
Initial analysis of the data revealed that a small number of hospitals reported 30-day in hospital 
mortality rates after AMI or stroke that were statistically significantly higher than expected at the 95% 
confidence level.
6
 Following discussion with the Quality and Patient Safety Directorate of the Health 
Service Executive (HSE) these hospitals were sent these preliminary findings in relation to their data.  
Many of these hospitals reviewed their HIPE and/or certain healthcare records. The extent and 
method of review varied by hospital, but the majority of hospitals undertook a review, led by a senior 
clinician, of the healthcare records of patients who died in hospital following admission with the 
principal diagnosis under investigation. As stated these hospitals identified a number of issues in 
relation to their data, including incorrect recording of the primary reason for admission (principal 
diagnosis) in the healthcare record and, to lesser extent, incorrect coding from the healthcare record 
into the HIPE system. The findings from these reviews are included in the text of the report.   
When this issue of data quality was highlighted by the hospitals which reviewed their data, all publicly 
funded acute hospitals were then communicated with by the office of Chief Medical Officer and the 
Quality and Patient Safety Directorate of the HSE. The hospitals were informed of this issue in 
relation to data quality and given the opportunity to review their data including the accuracy of their 
HIPE data specifically focusing on HIPE data for 2011.  
HIPE files for all hospitals from 2005 to 2010 were reopened on a phased basis starting with the 2010 
HIPE file in December 2011. During this phased opening some hospitals made retrospective changes 
to their data on the HIPE system. The hospitals that reviewed their records utilised different, and in 
some cases not comparable, methodologies in reviewing their data.    
Initially this study reviewed data from 2006 to 2010 using the closed HIPE files available in 2011. 
However the data presented in this final report are based on the revised HIPE files issued in 2012 to 
2013 for the years 2006 to 2010 unless otherwise stated. 
  
                                               
6
 Note that rates are said to be statistically significantly higher than expected when the lower limit of the 95% confidence 
interval is greater than 100. See Appendix 3 for further details.  
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Findings 
 
1.  In-hospital mortality within 30 days after acute myocardial infarction (AMI, 
heart attack) 
 
Indicator definition 
In-hospital mortality within 30 days after AMI is defined as the number of patients who die in hospital 
within 30 days of being admitted to hospital with a principal diagnosis of an AMI as a proportion of the 
total number of patients admitted to that hospital with a principal diagnosis of an AMI. Both crude 
mortality rates and age-standardised mortality ratios are calculated and presented by hospital, 
aggregated over the three-year period 2008–2010. This is an OECD indicator.   
 
Why is this important? 
Heart attack, or acute myocardial infarction (AMI), is one of the leading causes of death in Ireland.  
Heart attacks are life-threatening emergencies that happen when the coronary arteries, the blood 
vessels supplying blood to the heart muscle, are suddenly blocked. Lack of blood damages the heart 
muscle, weakening its function or stopping it altogether. AMI accounts for about half of the deaths 
from coronary artery disease (CAD), with the cost of care for CAD accounting for as much as 10% of 
healthcare expenditures in industrialised countries. 
Medical care for AMI has changed radically in recent decades, with the introduction of coronary care 
units in the 1960s, and the advent of drug treatment (thrombolysis) in the 1980s and cardiac 
procedures in the 1990s (angioplasty) aimed at rapidly restoring coronary blood flow. Evidence links 
the processes of care for AMI, such as thrombolysis and early treatment with aspirin and beta-
blockers, to survival improvements. The use of the 30-day mortality rate after AMI is a recognised 
outcome measure of acute care quality, and is one of the OECD Health Care Quality Indicators 
(HCQI).  
In-hospital mortality rates are considered by the OECD and other international agencies to be useful 
indicators of hospital care (AHRQ, 2013). These are high-level measures, the benefit of which is that 
they provide for a standard international approach, which allows for cross-country comparisons.  
However, there is an inevitable trade-off with the precision of the indicators, particularly the lack of 
inclusion of co-morbidities and other confounding factors. Another limitation with respect to in-hospital 
mortality rates is that factors outside of the hospital’s control, such as time to seeking treatment and 
pre-hospital care will affect these rates. In Ireland it is also not possible at present to track deaths 
which occur outside hospital within the 30-day period.  However, in-hospital mortality rates, while they 
must be interpreted with caution, are useful in identifying variation that should be explored further. 
 
Indicator Analysis 
The time trend for in-hospital mortality after AMI demonstrates a significant reduction nationally over 
the ten year period from 2001 to 2010 (Figure 1).   
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Figure 1: National age-standardised in-hospital mortality rate (ASDR) within 30 days after admission for 
AMI, 2001 - 2010. 
 
Note:  Data have been age-standardised to a standard population based on AMI admissions in 2008-2010. 
The OECD collects and reports in-hospital mortality rates for AMI in adults aged 45 and over. The 
OECD rates are age-sex standardised based on the 2010 OECD population aged 45+ admitted to 
hospital for AMI. This method of age-sex standardisation results in rates that cannot be directly 
compared to the ASDRs shown in Figure 1 above, but it allows for comparison among OECD 
countries.
7
 In 2011 (the latest year for which OECD data are currently available), the age-sex 
standardised rate for Ireland based on the OECD age-sex standardisation was 6.8 deaths per 100 
cases which was below the OECD average of 7.9 deaths per 100 cases (Figure 2).  
Figure 2: Admission-based in-hospital case-fatality rates in adults aged 45 and over within 30 days after 
admission for AMI, 2011 (or nearest year). 
 
Note: 95% confidence intervals represented by |—|. 
Source: OECD Health Statistics 2013. 
                                               
7
 See Appendix 3 for further details on the age standardisation methodology. 
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Age influences outcomes with, as expected, older age groups experiencing higher mortality rates. 
Therefore age-standardisation based on the population of admitted patients with AMI has been 
applied in this study in order to adjust for the differences in the age profile of patients between 
hospitals. However in this study other potential confounders e.g. co-morbidities, were not included in 
the analysis as this was a preliminary study to determine the feasibility of these indicators derived 
from HIPE.  
There are also significant volumes of patients transferred in and out of hospitals with AMI. Transfer 
status, i.e. whether a patient is transferred in or out of hospital, is recorded on HIPE.  However, HIPE 
is not designed to track patients and in the absence of a unique patient identifier it is not possible to 
accurately track individual patients between hospitals. A preliminary analysis of transfer patterns 
among hospitals was carried out. This analysis showed that the transfer patterns of each hospital may 
have a bearing on the mortality rates for that hospital, although the extent of this requires further 
investigation.  The issue of transfers is discussed further in Appendix 2.  
The clinical decision-making around both decision to and timing of transfer of patients to a centre for 
primary percutaneous coronary intervention (PCI) is likely to affect mortality rates. In hospitals that 
perform primary PCI, transfers in are likely to be patients transferred in for definitive intervention and 
transfers out are likely to be the repatriation of patients to their local hospital following intervention. In 
smaller hospitals transfers out are likely to be patients transferred out for definitive intervention and 
transfers in are likely to be the repatriation of patients to their local hospital following intervention.   
The initial analysis (based on HIPE data as of 2011) showed 30 day in-hospital mortality ratios after 
AMI varied by hospital with some reported mortality ratios that were statistically significantly higher 
than expected at the 95% confidence level. 
8
 
Following the initial analysis the Quality and Patient Safety Directorate of the HSE and the small 
number of hospitals showing mortality rates higher than expected were communicated with. Some of 
these hospitals then reviewed their healthcare records. This involved clinicians and other staff 
reviewing the healthcare records and coding practices in relation to AMIs. These reviews found that in 
some cases the information within the healthcare record that recorded the principal diagnosis of AMI 
was not correct, that there was not enough evidence of an AMI to diagnose an AMI and that in some 
cases the AMI was a complicating factor in another major illness. Some hospitals also identified 
variation in their coding practices and changes have been implemented to bring them into line with 
national coding guidelines.  
These reviews carried out by these hospitals although in some cases focused only on deaths after 
AMI, provided evidence of inconsistencies in health-care records, which may occur to a greater or 
lesser extent in all hospitals.   
The HIPE files for the years 2005 to 2010 for all hospitals were reopened on a phased basis starting 
from the end of 2011. A few hospitals took the opportunity to review and revise some of their HIPE 
data. A further analysis was then carried out in relation to this study of the revised HIPE data following 
the reopening of the HIPE files. In the case of the AMI indicator there are some differences in the 
calculated indicators using the original HIPE data and the revised HIPE data. One hospital made 
changes to their HIPE data for 2009 and 2010, leading to differences in both the numerator and 
denominator. This resulted in significant changes to their crude mortality rate and their age-
standardised mortality ratio, so that the SMR was no longer statistically significantly above the 
national average. These significant changes were also reflected in a reduction from 7.2 per 100 cases 
to 7.0 in the overall national mortality rate. This in turn led to minor changes in the age-standardised 
mortality ratios for all hospitals, although some hospitals still showed mortality ratios that were 
statistically significantly higher than expected at the 95% confidence level (Table 1 and Figure 3). 
  
                                               
8
 Where the lower limit of the 95% confidence interval is above 100 it can be said with 95% confidence that the rate is higher 
than expected and is statistically significant.  
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Table 1: In-hospital mortality within 30 days after admission for AMI, 2008 - 2010 
Hospital Number of Cases 
Crude Mortality 
Rate per 100 
Cases 
Age-standardised 
Mortality Ratio 
(SMR) 
Lower 95% 
Confidence Limit 
for SMR 
Upper 95% 
Confidence Limit 
for SMR 
1 1575 5.5 92.4 74.0 114.0 
2 1433 6.4 94.7 76.3 116.3 
3 1139 6.0 86.6 67.3 109.8 
4 1126 5.2 87.0 66.2 112.2 
5 994 5.6 79.6 60.1 103.4 
6 969 7.6 116.0 91.1 145.6 
7 862 7.4 105.2 81.0 134.4 
8 858 5.0 95.3 69.0 128.4 
9 852 6.1 82.3 61.5 107.9 
10 737 5.0 78.7 55.4 108.4 
11 573 14.5 159.2 126.8 197.4 
12 565 7.6 105.8 76.6 142.5 
13 538 4.5 74.9 48.0 111.5 
14 529 8.1 110.2 79.8 148.5 
15 510 10.2 117.1 87.5 153.6 
16 481 7.7 118.5 83.4 163.3 
17 419 5.3 68.4 42.9 103.6 
18 373 8.8 108.9 75.0 153.0 
19 366 7.7 108.3 72.0 156.5 
20 356 7.9 106.1 70.5 153.3 
21 336 11.6 140.4 99.8 191.9 
22 320 7.2 98.4 62.4 147.7 
23 313 8.6 126.5 83.4 184.1 
24 306 9.5 102.7 68.8 147.6 
25 277 9.4 130.3 85.1 190.9 
26 274 4.4 63.4 32.8 110.8 
27 270 8.9 107.9 69.1 160.5 
28 248 5.6 77.9 42.6 130.7 
29 190 6.8 88.7 47.2 151.6 
30 176 5.1 67.2 30.7 127.7 
31 175 7.4 83.2 44.3 142.4 
32 174 21.3 214.1 150.7 295.1 
33 161 8.1 107.0 57.0 182.9 
34 117 6.8 64.2 27.7 126.4 
35 94 2.1 26.4 3.2 95.5 
36 52 9.6 121.3 39.4 283.1 
Total 18738 7.0 100 94.6 105.4 
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Figure 3: Age-standardised mortality ratios (SMRs) and 95% confidence intervals for in-hospital mortality 
within 30 days after admissions with AMI, 2008 – 2010 
 
Note: 95% confidence intervals represented by |—|. 
 
Conclusion on the feasibility of the performance indicator 
This indicator fulfils some of the criteria for feasibility assessed in this study. For example the required 
variables are available in HIPE and there are sufficient numbers of cases for meaningful analysis. The 
indicator is based on an OECD indicator, 30-day in-hospital mortality following AMI, which has a 
standard definition therefore facilitating international comparison.  However, as a result of changes in 
definition and the availability of new biomarkers in the last decade the term, AMI, is little used now in 
clinical practice.  It is likely that at hospital level there is some crossover in assignment and coding of 
non ST elevated myocardial infarction (within AMI definition) and unstable angina (within the acute 
coronary syndrome definition). 
9
 
30 day in-hospital mortality after AMI measures death in hospital after AMI.  It is important to note that 
the indicator does not attribute the mortality to the principal diagnosis. It does not attribute the death 
to AMI as such. While on the one hand this may be seen as a limitation, on the other hand death in 
hospital following an AMI, whether from the AMI or another cause, may also be a reflection of quality 
of care.   
However this indicator does have a number of limitations. As there is no unique patient identifier the 
data are presented by admission episodes rather than by patient. Episode based indicators may lead 
to overestimation of the number of cases (denominator). The inclusion of a unique patient identifier 
would allow for the calculation of a patient based indicator. This would also support the tracking of 
patients between hospitals leading to an improvement in the reliability of this indicator.  
The 30-day mortality in hospital rates are likely to be affected by factors that occur before or after 
treatment within hospital, such as access and care prior to reaching hospital, within the emergency 
department or following discharge from hospital. Another factor that may be important is the transfer 
patterns among hospitals, and therefore development of systems that can capture this data would 
improve the measure.  
Patient factors including co-morbidities and medication use, patient help-seeking behaviour following 
onset of symptoms and social deprivation were not included in this analysis and are likely to affect 
                                               
9
 Note that the Australian Coding Standard ACS 0940 (Ischaemic Heart Disease) provides guidance on coding these 
conditions. 
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mortality rates. A more developed analysis that accounts for these may improve this aspect of the 
measure. 
However, one of the main issues highlighted by this preliminary analysis and the subsequent review 
by the HSE and the hospitals was that the reliability of this indicator is impacted on by a lack of 
consistency in the documentation of AMI in the healthcare record and coding onto the HIPE system.   
The observed variation in recorded in-hospital mortality rates is based directly on the data returned by 
each hospital to HIPE and so even in this preliminary form can be used by the hospitals and the HSE 
to indicate that further exploration and analysis would be beneficial in monitoring the quality of the 
care provided.  
A number of issues have been highlighted in this study including the quality of the data and the 
possible addition of other co-variables in the analysis that would strengthen this indicator. These 
issues should be taken into account in the further development and analysis of mortality indicators 
post AMI.  
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2. In-hospital mortality within 30 days after stroke  
 
Indicator definition 
This study assessed two indicators on in-hospital mortality rate after stroke. Based on OECD 
definitions, the study analysed mortality rates after both ischaemic stroke and haemorrhagic stroke. 
This study reports the findings and conclusions for each indicator separately. The indicators are 
defined as the number of patients who die in hospital within 30 days of being admitted to hospital with 
a principal diagnosis of ischaemic or haemorrhagic stroke as a proportion of the total number of 
patients admitted to that hospital with ischaemic or haemorrhagic stroke.  Both crude mortality rates 
and age-standardised mortality ratios are calculated and presented by hospital, aggregated over the 
three-year period 2008 – 2010.  These are OECD indicators.   
 
Why is this important? 
Stroke is a leading cause of mortality in Ireland. A stroke is the sudden death of brain cells in a 
localized area due to inadequate blood flow caused by a haemorrhage or ischaemia.  
Many patients who survive a stroke are left with disability. The impact of a stroke depends on what 
part of the brain is affected and how severe the damage is. The effects can range from mild 
impairments to devastating loss of abilities, including mobility, speech, vision or memory. These 
disabling effects of stroke leave more than half of stroke survivors needing some assistance in their 
day-to-day activities.  
Treatment for stroke has changed dramatically over the last decade. Until the 1990s, it was largely 
accepted that the damage to the brain was irreversible and treatment focused on prevention of 
complications and on rehabilitation. Now it is clear that thrombolytic treatment for ischemic stroke and 
timely diagnosis and therapy for all stroke victims in dedicated stroke units improves survival and 
limits disability.   
Variations in stroke mortality rates reflect many factors including early recognition of symptoms, 
seeking medical care as quickly as possible and possible differences in the care provided. 
Monitoring the proportion of patients who die in hospital after a stroke can be used to review practice 
patterns, monitor performance, and can lead to improvements in care. In-hospital mortality rates are 
considered by the OECD and other international agencies to be useful indicators of hospital care.  
These are high-level measures, the benefit of which is that they provide for a standard international 
approach, which allows for cross-country comparisons. However, as there is a lack of inclusion of 
other variables, for example co-morbidities, in these indicators there is an inevitable trade-off with the 
precision of the indicators. Another important limitation with respect to these in-hospital mortality rates 
are that factors outside of the hospital’s control, such as time to seeking treatment and pre-hospital 
care will affect these rates. In Ireland it has not been possible to track deaths which occur outside 
hospital within the 30-day period although this is something that may be possible in the future.  
However, in-hospital mortality rates, while they must be interpreted with caution, are useful in 
identifying variation that should be explored further. 
 
2.1 Indicator analysis: In-hospital mortality within 30 days after ischaemic stroke. 
Initially this study reviewed data from 2008 to 2010 using the closed HIPE files available in 2011. 
Subsequently all HIPE files from 2005 to 2010 were reopened and some hospitals made revisions to 
their HIPE data, e.g. some hospitals coded additional cases or revised the coding of previously 
reported cases. The data presented here are based on the revised HIPE files. An analysis was 
carried out of the HIPE data before and after the reopening of the HIPE files, and it was found that 
there were only minimal changes in the data which did not affect the identified statistically significant 
findings for the age-standardised mortality ratios.   
There has been a reduction in the 30-day age-standardised in-hospital mortality rate after ischaemic 
stroke over the ten year period from 2001 to 2010 (Figure 4).  
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Figure 4: National, age-standardised in-hospital mortality rate (ASDR) within 30 days after admission for 
ischaemic stroke, 2001 - 2010. 
 
Note: Data have been age-standardised to a standard population based on ischaemic stroke admissions in 2008-2010. 
The OECD collects and reports in-hospital mortality rates for ischaemic stroke in adults aged 45+. 
The OECD rates are age-sex standardised based on the 2010 OECD population aged 45+ admitted 
to hospital for ischaemic stroke. This method of age-sex standardisation results in rates that cannot 
be directly compared to the ASDRs shown in Figure 4 above, but it allows for comparison among 
OECD countries.
10
 In 2011 (the latest year for which OECD data are currently available), the age-sex 
standardised rate for Ireland based on the OECD age-sex standardisation was 9.9 deaths per 100 
cases which did not compare favourably with the average OECD rate of 8.5 per 100 cases (Figure 5).   
Figure 5: Admission-based in-hospital case-fatality rates in adults aged 45 and over within 30 days after 
admission for Ischaemic Stroke, 2011 (or nearest year) 
 
Note: 95% confidence intervals represented by |—|. 
Source: OECD Health Statistics 2013. 
                                               
10
 See Appendix 3 for further details on the age standardisation methodology. 
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There was variation in the mortality ratios of hospitals when age-standardised mortality ratios based 
on the population of admitted patients with ischaemic stroke were calculated as compared with the 
crude rates. This reflects and takes account of differences in the patient age profiles across hospitals 
(Table 2).    
There are significant volumes of patients transferred in and out of hospitals with stroke. Transfer 
status, i.e. whether a patient is transferred in or out of hospital, is recorded on HIPE.  However, HIPE 
is not designed to track patients and in the absence of a unique patient identifier it is not possible to 
accurately track individual patient between hospitals. A preliminary analysis of transfer patterns 
among hospitals was carried out. This analysis showed that the transfer patterns of each hospital may 
have a bearing on the mortality rates for that hospital, although the extent of this requires further 
investigation (see Appendix 2). 
 
Table 2: In-hospital mortality rate following ischaemic stroke within 30 days, by hospital, 2008 - 2010 
Hospital Number of Cases 
Crude Mortality 
Rate per 100 
Cases 
Age-
standardised 
Mortality Ratio 
(SMR) 
Lower 95% 
Confidence Limit 
for SMR 
Upper 95% 
Confidence Limit 
for SMR 
1 806 8.1 79.6 61.4 101.5 
2 756 11.0 94.9 75.6 117.7 
3 732 9.2 100.5 77.9 127.6 
4 720 8.6 79.7 61.1 102.2 
5 719 6.3 71.5 52.2 95.7 
6 680 10.3 90.8 70.8 114.7 
7 680 15.1 136.9 110.5 163.4 
8 662 8.2 82.6 62.1 107.8 
9 582 10.1 84.9 64.6 109.5 
10 474 10.5 87.3 64.8 115.1 
11 473 11.2 94.9 71.1 124.1 
12 468 10.9 95.0 70.8 125.0 
13 445 13.7 116.9 89.5 150.2 
14 441 8.8 80.0 56.9 109.4 
15 410 11.2 100.5 73.6 134.1 
16 410 11.7 95.1 70.1 126.1 
17 392 12.2 114.5 84.4 151.8 
18 384 9.1 80.2 55.9 111.5 
19 356 11.0 105.3 74.9 144.0 
20 344 18.3 155.1 119.1 198.4 
21 317 21.1 174.8 135.4 221.9 
22 313 11.2 99.7 69.4 138.6 
23 293 10.6 97.2 66.0 137.9 
24 290 8.3 80.3 51.5 119.5 
25 237 13.5 104.9 71.7 148.1 
26 219 15.5 124.8 86.4 174.4 
27 218 14.7 124.0 84.8 175.1 
28 212 8.0 75.9 44.2 121.5 
29 200 11.0 81.5 51.1 123.3 
30 195 7.2 63.7 34.8 106.9 
31 166 15.1 118.5 76.7 174.9 
32 145 25.5 209.2 147.3 288.4 
33 127 14.2 111.8 66.3 176.8 
34 75 20.0 162.9 91.2 268.6 
35 62 8.1 61.0 19.8 142.5 
36 51 17.6 189.0 86.4 358.8 
Total 14054 11.1 100 95.0 105.0 
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When adjusted for age some hospitals reported rates statistically higher than expected at the 95% 
confidence level in the period 2008-2010 (Table 2 and Figure 6). These hospitals were contacted by 
the Quality and Patient Safety Directorate of the HSE to highlight these issues. Some of these 
hospitals reviewed the healthcare records of all deaths after an admission for ischaemic stroke. The 
senior clinicians who reviewed the healthcare records concluded that based on the information within 
the healthcare record, the principal diagnosis of stroke as written in the healthcare record was not 
correct in a proportion of those records. These reviews were limited by the fact that they examined 
only deaths after ischaemic stroke, rather than examining all cases with a principal diagnosis of 
ischaemic stroke, and therefore the degree or direction by which these inconsistencies would affect 
the mortality rates could not be identified. However, they do provide evidence of inconsistencies in 
record keeping, which may occur to a greater or lesser extent in all hospitals.   
 
Figure 6: In-hospital Mortality rate following ischaemic stroke within 30 days, by hospital, 2008 – 2010 
 
Note: 95% confidence intervals represented by |—|. 
It was also noted that there were many instances where on review the primary cause of death was not 
stroke, although it was an antecedent cause. This highlights a characteristic of the OECD 30 day in-
hospital indicator used. 30-day in-hospital mortality after stroke measures death in hospital, after 
stroke. It does not attribute the death to stroke as such. While on one hand this may be seen as a 
limitation, on the other hand death in hospital following a stroke, whether from the stroke or another 
cause, may also be a reflection of quality of care.  
Other hospitals identified variation in coding practice in their HIPE records compared with their in-
house stroke register and other hospitals referred to developments in clinical care. 
 
Conclusion on feasibility of performance indicator: In-hospital mortality within 30 days after 
ischaemic stroke. 
This analysis shows that it should be feasible to use an indicator on in-hospital mortality rate within 30 
days after ischaemic stroke, derived from HIPE. However there are a number of significant limitations 
that impact on the reliability of this indicator.  
The reviews undertaken by a small number of hospitals showed a lack of consistency in the 
documentation of stroke in the healthcare record and the subsequent coding onto the HIPE system. 
Therefore the quality of the healthcare record and the data inputted should be improved to support the 
use of this indicator in the future.  
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It is important to note that the indicator does not attribute the mortality to the principal diagnosis. As 
there is no unique patient identifier the data are presented by admission episodes rather than by 
patient. Episode based indicators may lead to overestimation of the number of cases (denominator). 
The inclusion of a unique patient identifier would allow for the calculation of a patient based indicator. 
This would also support the tracking of patients between hospitals leading to an improvement in the 
reliability of this indicator.  
Patient factors including co-morbidities and medication use are likely to affect mortality rates and 
more developed analyses that may account for some of these issues may improve this measure. 
The 30-day mortality in hospital rates are likely to be affected by factors that occur before or after 
treatment within hospital, such as access and care prior to reaching hospital, within the emergency 
department or following discharge from hospital. Another factor that may be important is the transfer 
patterns among hospitals, and therefore development of systems that can capture this data would 
improve the measure. 
However it should also be noted that the observed variation in the recorded 30 day in-hospital 
mortality rates for ischaemic stroke is based directly on the data returned by each hospital to HIPE. 
Therefore even with the highlighted limitations it is still a useful measure in identifying areas requiring 
further exploration both in relation to data collection and quality clinical care. Further developments as 
described above can support this indicator in becoming a more reliable and useful indicator in the 
Irish health system. 
 
2.2 Indicator analysis: In-hospital mortality within 30 days after haemorrhagic stroke. 
Initially this study reviewed data from 2008 to 2010 using the closed HIPE files available in 2011. 
Subsequently all HIPE files from 2005 - 2010 were reopened and some hospitals made revisions to 
their HIPE data, e.g. some hospitals coded additional cases or revised the coding of previously 
reported cases. The data presented here are based on the revised HIPE files. An analysis was 
carried out of the HIPE data before and after the reopening of the HIPE files, and it was found that 
there were only minimal changes in the data which didn’t affect the identified statistically significant 
findings for the age-standardised mortality ratios.   
There has been little change in the 30-day age-standardised in-hospital mortality rate after 
haemorrhagic stroke over the ten year period from 2001 to 2010 (Figure 7).    
Figure 7: National, age-standardised in-hospital mortality rate (ASDR) within 30 days after admission for 
haemorrhagic stroke, as reported to HIPE, 2001 - 2010. 
 
Note: Data have been age-standardised to a standard population based on haemorrhagic stroke admissions in 2008-2010. 
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The OECD collects and reports in-hospital mortality rates for haemorrhagic stroke in adults aged 45 
and over. The OECD rates are age-sex standardised based on the 2010 OECD population aged 45+ 
admitted to hospital for haemorrhagic stroke. This method of age-sex standardisation results in rates 
that cannot be directly compared to the ASDRs shown in Figure 7 above, but it allows for comparison 
among OECD countries.
11
 In 2011 (the latest year for which OECD data are currently available), the 
age-sex standardised rate for Ireland based on the OECD age-sex standardisation was 26.2 deaths 
per 100 cases which was above the OECD average of 22.6 deaths per 100 cases (Figure 8).  
 
Figure 8: Admission-based in-hospital case-fatality rates in adults aged 45 and over within 30 days after 
admission for Haemorrhagic Stroke, 2011 (or nearest year)  
 
Note: 95% confidence intervals represented by |—|. 
Source: OECD Health Statistics 2013. 
 
There was variation in the mortality rates of hospitals when age-standardised mortality ratios based 
on the population admitted with haemorrhagic stroke were calculated as compared with the crude 
rates. This reflects and takes account of differences in the patient age profiles across hospitals.  
There are significant volumes of patients transferred in and out of hospitals with stroke. Transfer 
status, i.e. whether a patient is transferred in or out of hospital, is recorded on HIPE.  However, HIPE 
is not designed to track patients and in the absence of a unique patient identifier it is not possible to 
accurately track individual patient between hospitals. A preliminary analysis of transfer patterns 
among hospitals was carried out. This analysis shows that the transfer patterns of each hospital may 
have a bearing on the mortality rates for that hospital, although the extent of this requires further 
investigation (see Appendix 2).   
When adjusted for age a small number of hospitals reported rates that were statistically significantly 
higher than expected at the 95% confidence level while one hospital reported a statistically significant 
lower rate than expected (Table 3 and Figure 9). The hospitals with reported rates that were 
statistically significantly higher than expected were contacted by the Quality and Patient Safety 
Directorate of the HSE to highlight these issues and to provide follow up. 
  
                                               
11
 See Appendix 3 for further details on the age standardisation methodology. 
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Table 3: In-hospital Mortality rate following haemorrhagic stroke within 30 days, by hospital, 2008 - 2010 
Hospital Number of Cases 
Crude Mortality 
Rate per 100 
Cases 
Age-
standardised 
Mortality Ratio 
(SMR) 
Lower 95% 
Confidence Limit 
for SMR 
Upper 95% 
Confidence Limit 
for SMR 
1 1131 12.1 58.5 48.7 68.2 
2 550 18.4 84.3 67.9 100.8 
3 219 28.3 97.1 74.5 124.5 
4 213 28.6 112.4 86.0 144.3 
5 201 27.9 111.0 83.9 144.2 
6 197 23.4 96.7 70.8 129.0 
7 180 28.9 117.9 88.0 154.6 
8 168 28.6 122.3 90.1 162.1 
9 145 36.6 144.6 108.3 189.1 
10 130 36.9 148.1 109.2 196.4 
11 116 28.4 101.8 70.1 143.0 
12 115 32.2 114.6 80.7 157.9 
13 113 37.2 132.4 95.4 179.0 
14 107 32.7 118.6 82.6 165.0 
15 101 35.6 140.5 98.4 194.5 
16 99 34.3 121.9 84.4 170.3 
17 98 21.4 76.2 47.2 116.5 
18 95 25.3 104.2 66.8 155.1 
19 84 26.2 93.4 58.6 141.5 
20 84 32.1 118.2 77.9 172.0 
21 72 26.4 103.8 62.5 162.2 
22 68 27.9 103.8 62.5 162.1 
23 63 31.7 117.0 71.5 180.7 
24 59 35.6 124.1 76.8 189.7 
25 59 42.4 146.5 94.8 216.3 
26 57 28.1 124.4 71.1 202.1 
27 50 30.0 105.3 58.9 173.6 
28 48 37.5 157.9 93.6 249.6 
29 38 13.2 53.5 17.4 124.8 
30 33 39.4 136.9 72.9 234.0 
31 28 25.0 95.0 38.2 195.8 
32 27 25.9 85.8 34.5 176.8 
33 20 - - - - 
34 17 - - - - 
35 9 - - - - 
36 8 - - - - 
Total 4802 24.5 100 94.3 105.7 
 
Note: Rates based on small numbers of cases can be unreliable and as a result have very wide confidence intervals. For this 
reason the rates for hospitals with less than 25 cases are not shown in this table. 
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Figure 9: In-hospital Mortality rate following haemorrhagic stroke within 30 days, by hospital, 2008 – 2010 
 
Note: 95% confidence intervals represented by |—|. Hospitals with less than 25 cases are not shown in this graph. 
 
A senior clinician at one hospital audited the admissions for haemorrhagic stroke. It was found that 
there was insufficient information in a small number of records, but all the remaining cases had been 
correctly recorded in the healthcare record and entered onto the HIPE system as a haemorrhagic 
stroke as per the OECD definition. Another hospital identified variation in coding practice in their HIPE 
records compared with their in-house stroke register.   
It should be noted that although the OECD names the indicator ‘haemorrhagic stroke’, the ICD codes 
included cover other forms of non-traumatic intracranial bleeding, including non-traumatic subdural 
haemorrhage.   
 
Conclusion on feasibility of performance indicator: In-hospital mortality within 30 days after 
haemorrhagic stroke. 
This analysis shows that it should be feasible to use an indicator on in-hospital mortality rate within 30 
days after haemorrhagic stroke derived from HIPE. However there are a number of significant 
limitations that impact on the reliability of this indicator.  
The reviews undertaken by a small number of hospitals showed a lack of consistency in the 
documentation of stroke in the healthcare record and the subsequent coding onto the HIPE system. 
Therefore the quality of the healthcare record and the data inputted should to be improved to support 
the use of this indicator in the future.  
It is important to note that the indicator does not attribute the mortality to the principal diagnosis. As 
there is no unique patient identifier the data are presented by admission episodes rather than by 
patient. Episode-based indicators may lead to overestimation of the number of cases (denominator). 
The inclusion of a unique patient identifier would allow for the calculation of a patient based indicator. 
This would also support the tracking of patients between hospitals leading to an improvement in the 
reliability of this indicator.  
Patient factors including co-morbidities and medication use are likely to affect mortality rates and 
more developed analyses that may account for some of these issues may improve this measure. 
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The 30-day mortality in hospital rates are likely to be affected by factors that occur before or after 
treatment within hospital, such as access and care prior to reaching hospital, within the emergency 
department or following discharge from hospital.  Another factor that may be important is the transfer 
patterns among hospitals, and therefore development of systems that can capture this data would 
improve the measure. 
However it should also be noted that the observed variation in the recorded 30-day in-hospital 
mortality rates for haemorrhagic stroke is based directly on the data returned by each hospital to 
HIPE. Therefore even with the highlighted limitations it is still a useful measure in identifying areas 
requiring further exploration both in relation to data collection and clinical care. Further developments 
as described above can support this indicator in becoming a more reliable and useful indicator in the 
Irish health system. 
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3. In-hospital mortality within 30 days after hip fracture surgery  
 
Indicator definition 
In-hospital mortality within 30 days after hip fracture surgery is defined as the number of patients 
undergoing hip fracture surgery who die in hospital within 30 days of admission as a proportion of the 
total number of patients who underwent hip fracture surgery. Both crude mortality rates and age-
standardised mortality ratios are calculated and presented by hospital, aggregated over the five year 
period 2006 to 2010. This is not an OECD indicator.   
 
Why is this important? 
The international literature has found that surgical mortality may vary widely across hospitals and 
surgeons more so than would be predicted by chance alone or differences in case mix. Factors that 
may affect surgical mortality are procedure volume and access to effective multidisciplinary care. 
(Birkmeyer JD, et al, 2002; Ghaferi AA, Birkmeyer JD, and Dimick JB, 2009; Birkmeyer. JD and 
Dimick. JB, 2009)  
 
Indicator analysis 
Initially this indicator was based on data from 2006 to 2010 using the closed HIPE files available in 
2011. Subsequently all HIPE files from 2005 to 2010 were reopened and some hospitals made 
revisions to their HIPE data, e.g. some hospitals coded additional cases or revised the coding of 
previously reported cases. The data presented here are based on the revised HIPE files. An analysis 
was carried out of the HIPE data before and after the reopening of the HIPE files, and it was found 
that there were only minimal changes in the data which didn’t affect the findings for the age-
standardised mortality ratios.   
Nationally, age-standardised in-hospital mortality following hip fracture surgery has reduced over the 
10 year period from 2001 to 2010 (Figure 10).  
 
Figure 10: National, age standardised in-hospital mortality rate (ASDR) within 30 days following hip 
fracture surgery, as reported to HIPE, 2001 - 2010 
 
Note: Data have been age-standardised to a standard population based on admissions with hip fracture surgery in 2006-2010. 
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For the period 2006 to 2010, the national 30 day mortality rate following hip fracture surgery was 2.46 
deaths per 100 cases (Table 4 and Figure 11). Focusing on hospitals performing more than 500 
operations (over the five-year period), their crude mortality rates (unadjusted for age) ranged from 
1.43 deaths per 100 cases to 3.68 deaths per 100 cases. However, when adjusted for age no 
statistically significant differences were observed at the 95% level of confidence.  
 
Table 4: In-hospital Mortality rate following hip fracture surgery within 30 days, by hospital, 2006 - 2010 
Hospital Number of Cases 
Crude Mortality 
Rate per 100 
Cases 
Age-
standardised 
Mortality Ratio 
(SMR) 
Lower 95% 
Confidence Limit 
for SMR 
Upper 95% 
Confidence Limit 
for SMR 
1 2045 2.69 109.5 82.5 142.6 
2 1923 2.50 100.4 74.0 133.1 
3 1438 2.36 91.7 63.5 128.2 
4 1435 2.65 107.0 75.7 146.8 
5 1289 2.25 91.3 61.1 131.1 
6 1067 2.34 90.9 58.8 134.2 
7 979 2.45 102.7 65.8 152.8 
8 825 2.67 111.6 69.9 168.9 
9 774 2.07 89.8 51.3 145.9 
10 740 2.16 92.8 53.0 150.7 
11 668 1.65 69.4 34.7 124.2 
12 653 3.68 149.5 95.8 222.5 
13 639 2.97 116.0 69.8 181.1 
14 558 1.43 57.0 24.6 112.3 
15 543 3.50 136.8 82.4 213.7 
16 521 1.54 65.9 28.4 129.8 
17 16 - - - - 
18 8 - - - - 
19 6 - - - - 
20 <5 - - - - 
Total 16128 2.46 100 90.2 109.8 
 
Note: Rates based on small numbers of cases can be unreliable and as a result have very wide confidence intervals. For this 
reason the rates for hospitals with less than 25 cases are not shown in this table. 
 
The international evidence would suggest that low surgical volume is associated with poorer 
outcomes (Forte M et al, 2010; Ames JB et al, 2010) and it should be noted that the four hospitals that 
undertook fewer than 100 surgeries over the five-year period had ceased surgery by June 2010.   
Findings in hospitals with small numbers need to be interpreted with caution. Even aggregating the 
data over the 5 year period 2006 to 2010, the numbers of deaths remain small. The observed 
variations in this indicator do not result in statistical significance for any hospital.  
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Figure 11: In-hospital mortality rate following hip fracture surgery within 30 days, 2006 – 2010 
 
Note: 95% confidence intervals represented by |—|. Hospitals with less than 25 cases are not shown in this graph. 
 
Conclusion on the feasibility of the performance indicator 
Preliminary assessment of this indicator as derived from HIPE suggests that it offers good potential as 
an outcome measure. However, due to small relatively small numbers of procedures the observation 
of statistically significant variation is reduced even where that variation may be important clinically.  
In relation to the quality of inputting data to HIPE it is probable that both surgery and death are 
accurately recorded and therefore this is likely to enhance the reliability of this indicator.  
As the indicator refers to a procedure the lack of an individual patient identifier is less problematic in 
terms of potential double-counting, although its absence still restricts the ability to follow-up on 
patients after discharge from hospital.   
It is important to note that the indicator does not attribute the mortality to the principal procedure. Also 
the 30-day mortality in hospital rates are likely to be affected by factors that occur before or after 
treatment within hospital, such as access and care prior to reaching hospital, within the emergency 
department or following discharge from hospital. Another factor that may be important is the transfer 
patterns among hospitals, and therefore development of systems that can capture this data would 
improve the measure. 
It is also important to note that mortality following hip fracture is generally due to a medical condition 
and therefore medical care and the provision of an ortho-geriatric service may affect variation in 
outcomes following hip fractures. 
Patient factors including co-morbidities and medication use are likely to affect mortality rates and 
more developed analyses that account for some of these factors would improve this measure. 
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4. In-hospital mortality within 30 days after colectomy following emergency 
admission  
 
Indicator definition 
In-hospital mortality after colectomy following emergency admission is defined as the number of 
patients undergoing colectomy surgery following an emergency admission who die in hospital within 
30 days of admission as a proportion of the total number of patients who underwent a colectomy 
following emergency admission. Deaths following elective colectomies are rare and so elective 
admissions were excluded from this study. Crude mortality rates and age-standardised mortality ratios 
are calculated and presented by hospital, aggregated over the five year period 2006 to 2010. This is 
not an OECD indicator. 
 
Why is this important? 
The international literature has found that surgical mortality may vary widely across hospitals and 
surgeons more so than would be predicted by chance alone or differences in case mix. Factors that 
may affect surgical mortality are procedure volume and access to effective multidisciplinary care. 
Internationally 30-day mortality rates following surgery, including colectomies, are commonly used to 
measure quality of surgical care. (Birkmeyer JD, et al, 2002; Ghaferi AA, Birkmeyer JD, and Dimick 
JB, 2009; Birkmeyer. JD and Dimick. JB, 2009)  
 
Indicator analysis 
Initially this study reviewed data from 2006 to 2010 using the closed HIPE files available in 2011. 
Subsequently all HIPE files from 2005 to 2010 were reopened and some hospitals made revisions to 
their HIPE data, e.g. some hospitals coded additional cases or revised the coding of previously 
reported cases. The data presented here are based on the revised HIPE files. An analysis was 
carried out of the HIPE data before and after the reopening of the HIPE files, and it was found that 
there were only minimal changes in the data which did not affect the findings.   
Nationally age-standardised in-hospital mortality following colectomy after an emergency admission 
has reduced over the ten year period from 2001 to 2010 (Figure 12).   
Figure 12: National, age-standardised in-hospital mortality rate (ASDR) within 30 days after emergency 
admission and colectomy surgery, as reported to HIPE, 2001 - 2010. 
 
Note: Data have been age-standardised to a standard population based on emergency admissions with a colectomy procedure 
in 2006-2010. 
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For the period 2006 to 2010, the national 30-day mortality rate following colectomy after an 
emergency admission was 6.11 deaths per 100 cases. There was variation in the mortality ratios of 
hospitals when age-standardised ratios were calculated as compared with the crude rates. This 
reflects and takes account of differences in the patient age profiles across hospitals (Table 5 and 
Figure 13).  
 
Table 5: In-hospital Mortality rate following emergency admission & colectomy surgery within 30 days, by 
hospital, 2006 - 2010 
Hospital Number of Cases 
Crude Mortality 
Rate per 100 
Cases 
Age-
standardised 
Mortality Ratio 
(SMR) 
Lower 95% 
Confidence Limit 
for SMR 
Upper 95% 
Confidence Limit 
for SMR 
1 379 6.6 107.4 69.5 158.5 
2 363 4.7 84.7 49.3 135.6 
3 299 1.7 34.4 11.2 80.3 
4 269 7.4 120.0 73.3 185.3 
5 225 6.2 92.5 50.6 155.2 
6 186 6.5 110.6 57.1 193.1 
7 175 4.0 69.6 28.0 143.4 
8 163 6.8 116.8 58.3 208.9 
9 133 8.3 138.5 69.2 247.9 
10 130 9.2 136.0 70.3 237.6 
11 124 5.7 75.1 30.2 154.7 
12 114 7.0 111.6 48.2 219.8 
13 103 5.8 107.9 39.6 234.8 
14 102 5.9 91.5 33.6 199.1 
15 102 8.8 141.9 64.9 269.4 
16 93 7.5 136.5 54.9 281.2 
17 86 7.0 116.7 42.8 253.9 
18 84 3.6 42.5 8.8 124.1 
19 82 3.7 69.4 14.3 202.9 
20 75 8.0 125.0 45.9 272.1 
21 69 5.8 90.2 24.6 231.0 
22 60 8.3 126.1 40.9 294.3 
23 53 5.7 93.4 19.3 272.9 
24 51 5.9 97.0 20.0 283.5 
25 49 10.2 147.7 48.0 344.8 
26 32 15.6 230.3 74.7 537.3 
27 30 3.3 53.3 1.3 296.8 
28 29 10.3 143.7 29.6 419.9 
29 28 7.1 99.3 12.0 358.9 
30 25 12.0 202.3 41.7 591.3 
31 21 - - - - 
32 17 - - - - 
33 8 - - - - 
34 <5 - - - - 
35 <5 - - - - 
36 <5 - - - - 
Total 3767 6.11 100 87.1 112.9 
 
Note: Rates based on small numbers of cases can be unreliable and as a result have very wide confidence intervals. For this 
reason the rates for hospitals with less than 25 cases are not shown in this table. 
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Figure 13: In-hospital mortality rate following emergency admission & colectomy surgery within 30 days, 
by hospital, 2006 – 2010 
 
Note: 95% confidence intervals represented by |—|. Hospitals with less than 25 cases are not shown in this graph. 
There were no statistically significant higher than expected mortality ratios at the 95% confidence 
level recorded for emergency colectomy for any hospital, while one hospital recorded a statistically 
significantly lower than expected age-standardised mortality ratio.   
As with the other indicators in this analysis factors such as treatment prior to and after hospital 
admission and patient factors are not included in this analysis.  
 
Conclusion on the feasibility of the performance indicator 
Preliminary assessment of this indicator derived from HIPE suggests that it offers good potential as a 
future outcome measure. In statistical terms, small numbers, even with aggregation over several 
years, present a problem as the likelihood of observation of statistically significant variation is 
reduced. However on the other hand it is probable that details of surgery and the date of death are 
accurately recorded. It is also important to note that the indicator does not attribute the mortality to the 
principal procedure. 
Based on one hospital’s review of its data, the data recorded on the healthcare record and on HIPE 
appear to be reliable but a more extensive review would be required to assess data quality more 
widely across hospitals.  
As the indicator refers to a procedure the lack of an individual patient identifier is less of a problem in 
terms of potential double-counting, although its absence still restricts the ability to follow-up on 
patients after discharge from hospital.   
30-day mortality after colorectal surgery is a measure used frequently internationally as an indicator of 
care (although not always “in-hospital”), but this may not represent the true risk as it has been 
suggested by clinicians that longer than 30 days post operatively would provide a better measure of 
the risk of death after colorectal surgery. (Visser BC, Keegan H, Martin M, Wren SM., 2009) 
The 30-day in-hospital mortality rates are likely to be affected by factors that occur before or after 
treatment within hospital, such as access and care prior to reaching the hospital, within the 
emergency department or following discharge from hospital. Another factor that may be important is 
the transfer patterns among hospitals, and therefore development of systems that can capture this 
data would improve the measure. Patient factors including co-morbidities are likely to affect mortality 
rates and more developed analyses that accurately account for these would improve this measure. 
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5.  Time to hip fracture surgery 
 
Indicator definition 
The time to hip fracture surgery indicator is defined as the time from admission of a person aged 65 
years or older with a principal diagnosis of fractured neck of femur to time of surgery for the fracture. 
This is an OECD health care quality indicator. 
 
Why is this important? 
In Ireland the population is growing older and as the frequency of hip fracture is associated with 
increasing age this leads to a significant and increasing burden of illness in the community, including 
an increased risk of mortality and morbidity (Parker, 2006, Bentler 2009). 
Delay between admission and surgery, whether for medical stabilisation of the person’s co-
morbidities, or for administrative/logistical reasons, may increase length of hospital stay, and may also 
be associated with increased morbidity and mortality. A timely operation is known to improve 
outcomes (Simunovic N, Devereaux P, Spraque S et al, 2010).   
 
Indicator analysis 
Initially the study reviewed data for 2008 to 2010 based on the closed HIPE files available in 2011. All 
HIPE files from 2005 to 2010 were reopened and some hospitals made revisions to their HIPE data. 
The data presented here are based on the revised HIPE files. An analysis was carried out of the HIPE 
data before and after the reopening of the HIPE files, and it was found that there were only minimal 
changes in the data which did not affect the findings. 
Nationally, 80% of patients undergo surgery for hip fracture on the day of admission, the day after 
admission or 2 days after admission. There is a large variation across the country with the best 
performing hospital performing surgery on 95% of cases by day two and at the other end a hospital 
performing 58% of surgeries by day two (Table 6).  
 
Table 6: Time to hip fracture surgery, age 65+, by hospital, 2008 – 2010 
Hospital 
Number of Cases 
Aged 65+ with Hip 
Fracture Surgery 
Surgery on 
Day of 
Admission % 
Surgery 1 
Day after 
Admission % 
Surgery 2 
Days after 
Admission % 
Surgery 3 or 
More Days 
after 
Admission % 
Total % 
within 2 Days 
after 
Admission 
1 1094 14.4 32.8 23.6 29.3 70.7 
2 1037 25.5 46.7 10.2 17.6 82.4 
3 760 58.2 25.8 4.6 11.4 88.6 
4 756 26.2 38.1 18.7 17.1 82.9 
5 626 22.7 34.5 14.9 28.0 72.0 
6 551 40.8 43.6 4.7 10.9 89.1 
7 505 51.1 25.7 6.7 16.4 83.6 
8 420 22.9 44.8 9.0 23.3 76.7 
9 412 54.1 24.3 7.5 14.1 85.9 
10 389 41.4 31.6 10.8 16.2 83.8 
11 369 3.0 47.2 20.1 29.8 70.2 
12 356 37.6 53.7 3.4 5.3 94.7 
13 352 17.0 42.3 13.4 27.3 72.7 
14 300 15.3 30.0 13.0 41.7 58.3 
15 297 23.2 47.8 11.4 17.5 82.5 
16 268 24.3 45.1 13.8 16.8 83.2 
17 14 14.3 21.4 35.7 28.6 71.4 
Total 8506 30.0 37.5 12.4 20.1 79.9 
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The trend over the ten year period from 2001 to 2010 showed no significant change with a steady 
percentage in each time period. However there has been a slight rise in the proportion of cases with 
surgery on the day of admission (Figure 14).  
It should be noted that the time to hip fracture operation is based on day of admission rather than time 
at presentation and therefore it is likely that the actual times to surgery may be longer and that 
hospitals with long delays from ED to admission may appear to be performing better than they are. 
Figure 14: Time to hip fracture surgery for cases aged 65+, 2001 – 2010. Percentage of cases with 
surgery on day of admission, 1 day after admission or 2 days after admission 
 
Figure 15 shows the indicator on in-hospital waiting time for hip fracture surgery (age 65+) for the 
OECD in 2011 (the latest year for which data are available); with Ireland being above the OECD 
average. However a number of other countries achieve rates of over 90% suggesting that there may 
be potential for improvement.  
Figure 15: In-hospital waiting time for hip fracture surgery (age 65+), percentage within 2 Days. 2011 or 
latest year 
 
Source: OECD Health Statistics 2013. 
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Conclusion on feasibility of performance indicator 
This indicator derived from HIPE is useful as a high level indicator but has two significant limitations. 
Comprehensive time data is not recorded in HIPE. The international recommendation is to operate 
within 48 hours of admission. However without times of admission, day 2 could be anywhere from just 
over 24 hours to just under 72 hours following admission and therefore the indicator may not measure 
accurately best practice. However it should be noted that times of admission and discharge have 
been included in HIPE since 2011, although times of procedures are still not collected. 
Currently time in days from date of admission only is measured. This indicator could be improved if 
time from presentation in the emergency department (ED) to admission was also reported. Where 
delay occurs from ED to admission this is not reflected in the measure and therefore hospitals with 
long delays from ED to admission may appear to perform well where this is not the case.   
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6.  Age at orchidopexy 
 
Indicator definition 
Age at orchidopexy for the treatment of undescended testes is defined as the age at which 
orchidopexy is undertaken. This is reported as total number and proportion of cases by age group and 
region of residence. This is not an OECD indicator. 
 
Why is this important? 
Cryptorchidism is the absence of one or both testes from the scrotum.  About 3% of full-term and 30% 
of premature infant boys are born with at least one undescended testis, making cryptorchidism the 
most common birth defect of the male genitalia. However, about 80% of cryptorchid testes descend 
by the first year of life (the majority within three months), making the true incidence of cryptorchidism 
around 1% overall. 
The goal of a screening program is to detect all patients with undescended testes at an appropriate 
age and to refer them for orchidopexy (surgery to fasten an undescended testis into the scrotum).  
International evidence would suggest that timely surgery (at less than 2 years of age) reduces the risk 
of torsion, infertility and malignant transformation in later life (Ritzen E, 2008). 
Infants are screened for undescended testes upon discharge from the obstetric unit, at the six week 
GP check, by the public health nurse during routine visits, and in some areas by community medical 
officers at developmental assessment clinics. Delayed treatment can be an indication of differences in 
policies with respect to screening programmes; limited access to, or availability of, screening services; 
lack of clinical competence in identifying the diagnosis; or poor access to definitive surgical treatment.  
It is probable that some portion of late diagnosis is due to the testes ascending after an initial screen. 
There is evidence that acquired cryptorchidism, i.e. a testis present at birth which subsequently 
ascends, is more prevalent than previously thought. 
 
Indicator analysis 
Initially the study reviewed data for 2006 to 2010 based on the closed HIPE files available in 2011. 
HIPE files from 2005 to 2010 were reopened and some hospitals made revisions to their HIPE data. 
The data presented here are based on the revised HIPE files. An analysis was carried out of the HIPE 
data before and after the reopening of the HIPE files, and it was found that there were only minimal 
changes in the data which did not affect the findings. 
HIPE records children admitted for orchidopexy and therefore this indicator can be derived from HIPE. 
The number of cases of undescended testes undergoing orchidopexy at less than 2 years of age has 
not changed since 2006. However the indicator does show some variation across the country from 
16% in HSE West to 32% in Dublin Mid-Leinster (Table 7, Figure 16).   
Table 7: Orchidopexy - Total number and proportion by age group for orchidopexy, by HSE region of 
residence, as reported to HIPE, 2006 – 2010 
HSE Region of Residence 
Total Number of 
Orchidopexy Procedures 
Percentage Aged Under 2 
Years 
Percentage Aged Under 5 
Years 
Dublin Mid-Leinster 867 32.2 59.3 
Dublin North-East 685 28.8 61.3 
South 737 20.4 59.7 
West 720 16.3 55.6 
Total 3009 24.7 59.0 
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Figure 16: Orchidopexy - Percentage of procedures undertaken at age less than 2 years, by HSE region 
of residence, as reported to HIPE, 2006 - 2010.  
 
 
Overall, just over 40% of orchidopexy procedures undertaken in public hospitals are carried out at 5 
years of age or older. Figure 17 shows data for individual years by region and indicates little change 
in the percentage of procedures undertaken at less than 2 years of age since 2006. 
 
Figure 17: Orchidopexy: Percentage of procedures undertaken at age less than 2 years, by year and 
region of residence, as reported to HIPE, 2006-2010. 
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Conclusion on feasibility of performance indicator 
Preliminary assessment of this indicator suggests that it offers good potential as an outcome 
measure. Analysis of this indicator showed that there is a clearly defined procedure code in HIPE for 
this specific treatment of undescended testes. Age of admission for this procedure is likely to be 
documented accurately.  
However, there are a number of limitations, which should be borne in mind. It is not possible using 
HIPE data to ascertain the reason for later surgery, whether the problem was a failure of the 
screening process or difficulty accessing hospital or specialist care resulting in late treatment. Further 
exploration will be required to ascertain the underlying reasons for these findings.  
Therefore this indicator as derived from HIPE is a feasible measure of the timeliness of the treatment 
of undescended testes, although the reason for any delay would require further exploration. 
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7. Other indicators considered 
 
(a) Age at first hospital admission with developmental dysplasia of the hip (DDH) 
Indicator definition 
Age at first hospital admission with developmental dysplasia of the hip (DDH) is defined as age at first 
admission to hospital with a principal diagnosis of DDH. This is not an OECD indicator. 
Left untreated, DDH can lead to pain and osteoarthritis by early adulthood. The earlier DDH is 
detected the simpler and more effective the treatment is, with most children regaining normal hip joint 
function. The goal of the new-born screening programmes for DDH is to detect all children with DDH 
at the appropriate age and commence treatment. 
Infants are screened for developmental dysplasia of the hip upon discharge from the obstetric unit, at 
the six week GP check, by the public health nurse during routine visits, and in some areas by 
community medical officers at developmental assessment clinics. Therefore delayed diagnosis and  
treatment can be an indication of different policies with respect to the screening programme; poor 
access to, or availability of, screening services including targeted ultrasound; lack of clinical 
competence in identifying the diagnosis; or poor access to specialist services and definitive treatment. 
Indicator analysis 
The initial analysis showed higher numbers than expected being admitted at age 2 years and over, 
and suggested an increasing trend in admissions of older children, which may highlight that further 
analysis and exploration is required. However there could be multiple reasons why children aged over 
2 could be admitted or re-admitted, including diagnosis and treatment without previous admission, or 
repeat admissions for follow up of late diagnosis of DDH.   
From HIPE it is not possible to identify age at first assessment, as there is no record of outpatient 
attendances in the HIPE system. Therefore it is not possible to differentiate those children who were 
appropriately identified, initially managed conservatively in the outpatient clinic and then admitted 
after a decision was made to move to more invasive treatment, from those children who were 
identified late and hence required more invasive treatment from first presentation.   
Conclusion on the feasibility of the performance indicator 
The analysis found that there are a number of limitations with using HIPE data for this indicator. For 
example, it is possible that children who present to different hospitals may be counted more than once 
due to the fact that HIPE is not designed to track patients between hospitals. In some areas due to 
upgrades to the patient administration system (PAS), patients who were readmitted to the same 
hospitals received new medical record numbers and so it was not possible to track these patients in 
the same hospitals. Lack of primary care and outpatient data in HIPE means that it is not possible to 
measure cases which are treated in primary care or on an outpatient basis.   
While HIPE data can provide some information on hospital admissions for DDH, it cannot be 
interpreted as a commentary on the management of this condition. Therefore a childhood registry or 
other data system with more comprehensive information on the management of DDH both in 
community, primary care and acute care services could be of more benefit in developing performance 
indicators to monitor how a service manages this condition.  
 
(b) Rate of pulmonary embolism (PE) or deep vein thrombosis (DVT) following surgery 
Indicator definition 
Number and percentage of patients who develop pulmonary embolism (PE) or deep vein thrombosis 
(DVT) following surgery. This is an OECD indicator. 
A PE post-surgery is a serious and possibly life threatening condition. However below knee DVTs are 
often asymptomatic and may not need any treatment.  
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Conclusion on the feasibility of the performance indicator 
This indicator was calculated but rejected due to the small numbers being recorded in the HIPE 
system. The findings of low rates and large variations may indicate that these data are not being 
systematically recorded, either in the patient notes or else are being recorded in the patient notes and 
are not being inputted onto the HIPE system. Discussion with clinicians indicated that it is likely to be 
a variation in clinical practice around screening for and identifying DVT that is leading to variations in 
the findings. PE rates are generally considered accurate given that this is such a serious 
complication. However, the rate of diagnosis of DVT is likely to vary greatly by hospital. If all patients 
are scanned post-surgery for DVT then the detection rate will be high; if only symptomatic patients are 
scanned then the detection rate will be much lower.   
This is currently an OECD indicator although the OECD HCQI expert group is reviewing this indicator 
with a view to further refinement and improvement. Therefore the feasibility of this indicator may be 
reconsidered in the future.  
 
(c) Rate of catheter-related blood stream infections 
Indicator definition  
Number and percentage of patients who develop catheter-related blood stream infections as a 
consequence of their hospital care. 
Conclusion on the feasibility of the performance indicator 
This indicator was calculated but rejected due to small numbers being recorded in the HIPE system. 
The findings of low rates and large variation may indicate that these data are not being systematically 
recorded, either in the patient notes or else are being recorded in the patient notes and are not being 
inputted onto the HIPE system. This was confirmed by clinical experience. Another factor that may 
affect this indicator is the implementation of hospital screening policies which could increase numbers 
in these hospitals.  
Data for this indicator sourced from hospital discharges databases was previously collected by the 
OECD, but this was discontinued as it was considered that ambiguities in the definition meant the 
indicator was not fit for reporting.  
There are other potential data sources within the Irish health system that may provide more 
comprehensive and reliable information on catheter-related blood stream infections. Therefore it was 
concluded that the HIPE system is unlikely to be the most useful source of information for this 
indicator in the future.  
 
(d) Patients with STEMI who have received thrombolysis or cardiac catheterisation within the 
following 24 hours  
Indicator definition 
Number and percentage of patients with STEMI who have received thrombolysis or cardiac 
catheterisation within the following 24 hours. 
ST segment elevation myocardial infarction (STEMI) occurs when a coronary artery is totally occluded 
by a blood clot. 
Conclusion on the feasibility of the performance indicator 
This indicator as derived from HIPE was not considered feasible for two reasons. Firstly, HIPE does 
not provide a measure of time in hours which precludes accurate calculation of this indicator. 
Secondly, HIPE is not designed to capture emergency department activity.  Since door to needle time 
is the key measure for this indicator, the HIPE system cannot, therefore, provide an accurate 
estimation of response times.  
Alternative methods and potential data sources to support the measurement of this indicator should 
be examined.  
 - 36 - 
(e) Number of falls in hospitals as a percentage of all inpatient discharges  
Indicator definition 
Number of falls in hospitals as a percentage of all inpatient discharges.  
Conclusion on the feasibility of the performance indicator 
The intention of this indicator is to reflect care during a hospital stay. This indicator as derived from 
HIPE was not considered to be feasible for a number of reasons. In order to calculate this indicator 
reliably, reasonably complete information is required for the external cause variable “place of 
occurrence” where a fall is recorded as an external cause of injury. However it was found on review 
that approximately 40% of discharges with an external cause of injury had the place of occurrence 
coded as unspecified or else not coded at all.   
Also, prior to 2011, it was not possible to determine from HIPE data whether the fall took place in the 
hospital of treatment or if it took place in some other health service area. The inclusion of the hospital 
acquired diagnosis flag in HIPE since 2011 should assist in overcoming this and support the 
implementation of this indicator in the future.  
An indicator on falls in hospitals and in other healthcare settings is currently being developed as part 
of the national suite of nursing performance indicators.  
 
(f) Rate of ventilator associated pneumonia (VAP) 
Indicator definition 
Number of ventilated patients who develop associated pneumonia (VAP). 
Conclusion on the feasibility of the performance indicator 
According to the literature VAP complicates the course of up to 47% of intubated patients and may 
have a mortality rate as high as 50%. 
However for ventilator associated pneumonia, there is no specific code in the edition of the ICD-10-
AM classification currently used for HIPE data. Instead, the coding guidelines state that this diagnosis 
should be coded using a combination of 4 diagnoses: 
 J95.8 [Other post-procedural respiratory disorders] 
 type of pneumonia 
 Y84.8 [Other medical procedures as the cause of abnormal reaction of the patient, or of later 
complication, without mention of misadventure at the time of the procedure, Other medical 
procedures] 
 Y92.22 [Place of occurrence: health service area]. 
This combination of codes is rarely recorded on HIPE which suggests that VAP is not being fully 
coded when it occurs. This may be due to the limit of 20 diagnoses on HIPE which pertained prior to 
2011. Patients requiring ventilation may have over 20 diagnoses recorded on the healthcare record, 
and it is possible that some of the 4 diagnoses required for VAP to be identified may be omitted from 
HIPE. It is important to note that the number of diagnoses that can be recorded per case on HIPE was 
increased to 30 in 2011. However, at present the VAP indicator is not considered feasible. It would 
appear likely that the increased number of diagnoses permissible on HIPE will only marginally 
improve identification of VAP cases and that other options (e.g. inclusion of a specific ICD-10-AM 
code for VAP) will need to be considered if accurate measurement of this indicator is to become 
feasible in the future. 
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Discussion 
While it must be stressed that HIPE was originally established as a discharge-based system to 
measure type and volume of hospital activity, it also provides a rich source of data on patient 
discharges from all publicly funded acute hospitals in Ireland. It is a well-developed database and 
care is taken to ensure its accuracy and completeness. This study confirms that there are many 
strengths of the HIPE system, as a suitable database, albeit with some improvements, to derive 
indicators to measure outcomes in Irish healthcare. HIPE data are routinely collected and therefore 
much less additional cost or resources would be required in utilising/developing it to measure 
outcomes compared with developing a de novo indicator dataset. The data are collected in all public 
hospitals enabling comparison across the entire acute public hospital system. It is a flexible system 
where improvements and additions are made on an on-going basis in response to service need and 
recommendations, e.g. a flag for hospital acquired diagnoses was added to HIPE for discharges from 
2011.   
To a large extent this work builds on the Health Care Quality Indicators (HCQI) project led by the 
OECD, and it should be viewed as a starting point in utilising hospital discharge data to monitor 
quality of care at hospital level. The OECD HCQI project shows that high level indicators based on 
specific diagnoses and/or procedures are valuable as a first step in the comparison of performance 
and, where possible, relevant indicator definitions and guidelines from the HCQI project have been 
adopted for this paper. This provides for a standard international approach and allows for cross-
country comparisons. The use of high level indicators (i.e. based on principal diagnosis) by the OECD 
is one way in which the effect of differences in coding practices can be minimised since the policy and 
practice of coding secondary diagnoses can vary significantly between countries.   
In relation to the indicator definitions a number of caveats must be highlighted. In-hospital mortality 
rates and ratios are considered by the OECD and others to be useful indicators but must be 
interpreted with particular caution. International literature on performance indicators warns against the 
precise interpretation of the correlation between in-hospital mortality rates and hospital performance. 
The literature supports the approach that there should not be a single measure of performance or 
safety but that there needs to be a range of indicators. 
The indicators in this report are high level indicators which adjust for differences in the age distribution 
of patients between hospitals. They do not purport to take account of other significant factors which 
may affect the comparison of outcomes. Such factors include, inter alia, co-morbidities, levels of 
deprivation, transfer patterns, pre-hospital care etc. Analysis of the effect of the presence of co-
morbidities and other potential confounding factors would be an obvious further step in the 
development of these indicators.   
It is important to note that the mortality measures here are based on patients who die within 30 days 
of hospital admission following the principal diagnosis or procedure under examination and that the 
measure does not directly attribute the death to that principal diagnosis or procedure. This may be a 
limitation or it may also be a valid measure of care, as unexpected death in hospital may in itself 
reflect a broader view of care received.   
In some cases, indicators initially considered were not included after review of initial results and the 
identification of limitations associated with the data. For example, number and percentage of patients 
with ST elevated myocardial infarction (STEMI) who have received thrombolysis or cardiac 
catheterisation within the following 24 hours was not feasible to measure since data on any treatment 
and time to treatment given in the emergency department is not included in HIPE.  
Three to five years of data were aggregated in order to have adequate numbers to test for 
significance in smaller hospitals. However by aggregating data, changes in outcomes over the period 
studied could not be identified, although 10 year trends at national level were examined. Despite 
aggregating data over several years, in certain instances, age-standardised ratios were still based on 
small numbers. The statistical confidence limits associated with these ratios were very wide and do 
not provide evidence of a significant difference from the national.  
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It is recognised that there are limitations in utilising the data as currently recorded in the HIPE system 
in order to measure outcomes related to quality of care. A small number of hospitals showed 
statistically significantly higher rates than expected at the 95% confidence level for specific indicators. 
Some of these hospitals reviewed their healthcare records and HIPE data and identified 
inconsistencies in both the accuracy and completeness of their healthcare records and their HIPE 
data. Most hospitals that reviewed their healthcare records found that some portion of those 
healthcare records had the principal diagnosis incorrectly recorded in the healthcare record. These 
hospitals found that the errors or omissions occurred principally in the healthcare record rather than in 
the recording of the healthcare record information by the HIPE coders. These problems may be 
occurring more widely across hospitals. However in order to identify the full extent of these issues a 
more systematic audit approach is needed, for example an audit of stroke and AMI admissions data 
across all hospitals. The ESRI provided a HIPE Coder Audit Tool that may provide a useful support in 
undertaking such audits. 
The reviews undertaken by the hospitals that showed statistically significantly higher rates in specific 
indicators identified documentation, data and clinical care issues that may have explained this 
variation. However it is important to note that the review by these hospitals used different 
methodologies and therefore their findings may not be comparable or transferrable.   
The HIPE files for 2005 to 2010 were reopened on a phased basis starting in 2011. Subsequently a 
number of hospitals made changes to their data, including some of the hospitals that reviewed their 
data as a follow-up to the issues highlighted in this study. However, caution must be exercised in 
making selective changes retrospectively to HIPE data following identification of an outlying result, as 
there is the potential that data may be adjusted at the expense of identifying a real clinical problem. 
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Conclusions 
Internationally the use of quality indicators to measure health service performance is recognised as 
an important initiative in improving the quality, effectiveness and safety of healthcare. In line with this 
approach and building on the work of the OECD through the Health Care Quality Indicators (HCQI) 
project, the Department initiated this study as an important first step in assessing the feasibility of 
indicators derived from HIPE as potential indicators to be used by the Irish health system to measure 
health service performance.  
The report highlights important issues in a number of areas including the importance of data quality in 
developing and implementing indicators. Its focus is on the value of HIPE, on the importance of data 
quality and on the benefit to the health system of good quality data. For this reason individual 
hospitals are not identified in this report. 
This report confirms the value of the HIPE system as a resource for the development of indicators of 
quality of care in hospitals in Ireland. At the same time it draws attention to areas where HIPE may 
not be suitable and/or where additions and improvements to HIPE will be required prior to using these 
measures as reliable outcome indicators. The report also highlights the requirement for hospitals, with 
guidance from the HSE, to improve the quality and accuracy of the information that they record, both 
in the healthcare record and subsequently onto the HIPE system. It is also the case that in the context 
of the health reform programme the quality of HIPE data is becoming ever more important since the 
implementation of policies such as “Money follows the Patient” and Universal Health Insurance 
require the use of Diagnosis Related Groups (DRGs) which are based on HIPE. 
The preliminary analysis undertaken as part of this study has highlighted factors that may have a 
confounding effect on the findings, particularly in relation to the in-hospital mortality indicators. One of 
the most significant risk factors affecting mortality is age as the number and severity of co-morbidities 
usually increases with age. The in-hospital mortality indicators have been age-standardised as part of 
the methodology used in this study in order to adjust for varying age profiles of patients in different 
hospitals. However, other confounding factors such as co-morbidities, which may influence outcomes, 
need to be addressed through subsequent refinements of the methodology including the addition of 
further variables in the analysis. The potential effect of transfers of cases between hospitals also 
requires further study.  
The analysis of hospital level data has highlighted the limitation of small or very small numbers when 
developing and reporting indicators. Small numbers can result in unstable and unreliable rates and 
problems with confidentiality. There are ways to try and counteract this for example by aggregating 
years, by grouping hospitals, or combining clinical groups. This report has addressed some of these 
issues through the aggregation of several years of data and the inclusion of 95% confidence intervals. 
Analysis of the effect of the presence of co-morbidities and other confounding variables such as social 
deprivation would be an obvious next step in any further analysis of these indicators. However it 
would also be very beneficial if a further assessment and implementation of identified improvements 
to data quality were carried out in advance of this process. It should also be noted that the 
introduction of a unique patient identifier would greatly assist in developing accurate and robust 
indicators. Linking to other datasets, such as Central Statistics Office mortality data also has the 
potential to improve indicators. 
This study has shown that some of the data used in the calculation of these indicators was unreliable 
due to lack of consistency in the documentation in the healthcare record and subsequently the 
transfer onto the HIPE system. However this is data entered directly by the hospitals and therefore 
the quality of the healthcare record and the inputted data is the responsibility of the hospital. This data 
is an important source of information for the hospitals, for the health system and also for the public. 
Indicators derived from data entered by the hospital onto HIPE allow hospitals to monitor their own 
performance over time. This ability to compare outcomes over time and across services is an 
important function and it is essential for service providers to have high quality information available to 
them that allows them to do this.  
 - 40 - 
The observed variations across hospitals found in this study may be due to a number of factors 
including quality of care issues, data quality issues or issues in relation to the inclusion of confounding 
factors in the analysis. It identifies issues in regard to the quality of the data, and in particular the 
medical record, which need to be addressed in order to support further analysis and more targeted 
interpretation of results. Nevertheless, the report has demonstrated the value of calculating quality 
indicators based on HIPE data and has identified areas requiring further exploration both in relation to 
data collection and clinical care. 
The findings set out in this report should not be taken as making any inferences concerning quality of 
care in hospitals and certainly should not be interpreted as ranking hospitals with respect to the 
selected indicators. It is accepted that indicators are alerts or flags to identify areas of performance 
that may require further exploration. In addition indicators can help to identify good practice which can 
then be disseminated throughout the system. However it must be noted that the international literature 
on performance indicators warns against using a specific measure as a generic indicator of an 
organisation’s performance and safety and also highlights the limitations of the precise interpretation 
of the correlation between in-hospital mortality rates and hospital performance. Indicators should be 
assessed within the context in which care is delivered and should not be reviewed in isolation. 
Quality indicators should be used by clinical and management teams to measure the quality of care 
delivered. Following further exploration, and if required, a quality improvement plan that can be 
monitored and evaluated over time should be put in place and systematically implemented.  
This report provides a preliminary analysis of indicators derived from reported HIPE data, which 
serves principally to highlight the potential of the selected indicators but also raises important 
questions. This study will inform the future development of healthcare quality indicators for Ireland. 
These indicators, aligned with international evidence-based practice, should be implemented and 
reported on at all levels of the Irish health system and internationally. 
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Response to the Report 
 
The Hospital Inpatient Enquiry System (HIPE), within certain parameters, will be used by the 
Department of Health (DoH), the Health Service Executive (HSE) and other relevant health service 
providers, to derive performance indicators to measure the performance of health services in 
delivering quality and safe healthcare. These parameters include that the data in HIPE is validated, 
accurate high quality data. 
Clear governance mechanisms at both a national, regional and local level for the quality of HIPE will 
be established including a national governance group and clear service level agreements with service 
providers. Those responsible for the quality of HIPE both at the national level, that is the HSE and at a 
local level, for example acute hospitals, should ensure continuous improvement in the quality of HIPE 
through implementation of quality improvement programmes. These quality improvement 
programmes should include regular audits along the data flow pathway and education and training 
programmes for clinical staff and administrative staff involved in HIPE. Under these governance 
arrangements and as part of the annual review process of HIPE variables, specific additions will be 
considered which would enhance the value of HIPE for measuring performance.   
The Department of Health will develop a formal public national reporting system by the Minister for 
Health in relation to National Healthcare System Quality Performance Indicators for Ireland. These 
performance indicators and targets will be aligned with evidence-based international practice and 
linked to international norms, e.g. OECD Health Care Quality Indicators, wherever possible. The DoH 
in establishing the reporting mechanism for National Healthcare System Performance Quality 
Indicators will engage with all key stakeholders including the HSE and HIQA.  
The indicators which were assessed to be feasible in this report will be further developed and 
evaluated by the DoH and the HSE in consultation with key stakeholders. The DoH, the HSE and the 
wider healthcare system will also continue to develop and report evidence-based quality of care and 
outcome indicators in line with each organisation’s mandate.  
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Appendix 1: Detailed Methodology 
HIPE Files  
The analysis presented in this report was updated in 2013 to include the revisions made to the HIPE 
files in 2012. The versions of the HIPE files used were as follows: 
2006_AsOf_0113_V27_Close 
2007_AsOf_0213_V26_Close 
2008_AsOf_0213_V28_Close 
2009_AsOf_0812_V21_Close 
2010_AsOf_1212_V21_Close 
 
 
Presentation of Tables & Graphs 
Hospital names are not included in this report. The data in each table has been sorted by the highest 
number of cases, and the hospitals have been numbered accordingly. Note that hospitals have been 
numbered for each indicator separately, and so for example, hospital 1 in one table is not necessarily 
the same hospital as hospital 1 in a different table.  
The same hospital numbers have been used in the associated graphs. Note that rates based on small 
numbers of cases can be unreliable and as a result have very wide confidence intervals. Therefore 
rates for hospitals with less than 25 cases are not shown in the tables or displayed in the graphs. The 
data from these hospitals have however been included in the calculation of the overall national rates. 
 
Method of Calculation of Indicators 
1. In-hospital mortality within 30 days following acute myocardial infarction (AMI) 
Numerator: Discharges with a discharge code of 06 (died with post mortem) or 07 (died no post 
mortem) and length of stay of ≤ 30 days, among cases in the denominator with principal diagnosis of 
AMI (ICD-10-AM I21 or I22).  
Denominator: The total number of discharges with a principal diagnosis of ICD-10-AM I21 or I22 and 
aged 15 years or over. 
Time period: 2008-2010 
Note: As this is one of the OECD Health Care Quality Indicators, the OECD definitions were used in 
order to provide for international comparability.  
 
2. In-hospital mortality within 30 days following stroke 
Numerator: Discharges with a discharge code of 06 (died with post mortem) or 07 (died no post 
mortem) and length of stay of ≤ 30 days, among cases in the denominator with principal diagnosis of 
ischaemic or haemorrhagic stroke.   
Denominator: Total discharges with a principal diagnosis of ICD-10-AM I63 or I64 (ischaemic stroke) 
or ICD-10-AM I60-I62 (haemorrhagic stroke), aged 15 years and over. 
Time period: 2008-2010 
Note: As this is one of the OECD Health Care Quality Indicators, the OECD definitions were used in 
order to provide for international comparability.   
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3. In-hospital mortality within 30 days following hip fracture surgery 
Numerator: Discharges with a discharge code of 06 (died with post mortem) or 07 (died no post 
mortem) and length of stay of ≤ 30 days, among cases in the denominator.  
Denominator: The number of discharges aged 15 years and older with a principal diagnosis of 
fracture of neck of femur (ICD-10-AM S72.0, S72.1, S72.2) and a principal procedure for treatment of 
the hip fracture (ICD-10-AM ACHI procedure blocks 1479,1486,1489,1487,1488,1491,1492).  
Time period: 2006-2010.  
Note: The procedure codes were selected after investigation of the types of procedures that patients 
with hip fractures were undergoing. The principal diagnosis codes selected were those used by the 
OECD to identify hip fractures.  
 
4. In-hospital mortality within 30 days following emergency admission and colectomy 
Numerator: Discharges with a discharge code of 06 (died with post mortem) or 07 (died no post 
mortem) and length of stay of ≤ 30 days, among cases in the denominator. 
Denominator: The number of patients aged 15 and older with a principal procedure code of ICD-10-
AM ACHI procedure blocks 913 (colectomy) or 936 (total proctocolectomy), excluding cases with an 
elective admission or elective readmission (admission codes 1 or 2).   
Time period: 2006-2010.  
 
5. Time to surgery following hip fracture  
Numerator: The number of cases in the denominator based on the difference between the date of the 
principal procedure and the date of admission.   
Denominator: The number of discharges aged 65+ with a principal diagnosis of hip fracture (ICD-10-
AM S72.0, S72.1, S72.2) and a principal procedure of hip fracture surgery (ICD-10-AM ACHI 
Procedure Blocks 1479, 1486,1487, 1488, 1489, 1491 or 1492).  
Time to surgery calculation: In the absence of data on times of admission and procedures, surgery 
within 2 days refers to discharges where surgery took place on the day of admission, the following 
day or 2 days after admission (i.e. day 0, day 1 or day 2).  Date of the principal procedure is used, 
rather than date of first procedure, as the principal procedure is one that is performed for definitive 
treatment, rather than one performed for diagnostic or exploratory purposes. 
Time period: 2008-2010  
Note: As this is one of the OECD Health Care Quality Indicators, the OECD definitions were used in 
order to provide for international comparability.  
 
6. Age at orchidopexy 
Numerator: The number of cases under 2 years of age, and under 5 years of age among cases in 
the denominator. 
Denominator: Total discharges with a principal or secondary procedure of orchidopexy for 
undescended testes (ICD-10-AM ACHI Procedure Block 1186) 
Area: HSE region of residence  
Time period: 2006-2010 
Note: Revision orchidopexy procedures were excluded.   
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Appendix 2: Transfers  
An important consideration in the assessment of in-hospital mortality rates is the issue of transfers. 
Patients can be discharged from one hospital by being transferred into another hospital. For example 
in the case of an AMI, a patient may first be admitted to a hospital and then transferred to a different 
hospital for further treatment. In this case the patient will be counted in both hospitals in the analysis 
presented here if the principal diagnosis in both cases is recorded as an AMI. Patients can also be 
temporarily transferred to another hospital for a particular purpose, for example for a day case cardiac 
procedure, while also remaining as an inpatient in the first hospital. The patients who are transferred 
in or out of hospitals may have different complexity issues or comorbidities than those patients who 
were not transferred. These factors have the potential to influence the in-hospital mortality rates.   
In order to investigate this, the volume of transfers was investigated for each of the in-hospital 
mortality indicators. Where the data showed that there were large numbers of cases being transferred 
between hospitals, preliminary analysis was undertaken whereby the mortality rates were examined 
for different groups of cases, i.e. cases who were transferred into hospitals; cases who were not 
transferred into hospitals, and cases who were not transferred out to other hospitals. Note that cases 
that were transferred out to other hospitals were all by definition, alive on discharge and so the in-
hospital mortality rates were not relevant for this group of cases.  
The preliminary analysis showed that for some of the indicators considered in this study, there were 
significant numbers of patients being transferred both in and out of hospital, which has the potential to 
have a bearing on the in-hospital mortality rates. However a more refined analysis would be required 
in order to assess the full effect.  
A summary of the analysis of the transfers data for each of the in-hospital mortality indicators is 
included below.  
 
In-hospital mortality rate within 30 days after AMI 
A significant number of cases had a discharge type indicating a transfer out to another hospital (30%) 
or had a source of admission indicating a transfer in from another hospital (19%). Overall 39% of 
cases were either transferred in to one hospital or transferred out of another. As expected the number 
of transfers into hospital does not match the number of transfers out of hospitals. There are a number 
of reasons for this, including transfers to or from hospitals that do not participate in HIPE (e.g. private 
hospitals or non-acute hospitals) and temporary transfers of patients to a different hospital for a 
particular procedure. Also, patients are assigned a principal diagnosis in each hospital independently 
of the principal diagnosis that was assigned in a previous hospital. For example a patient may be 
admitted to a hospital with a principal diagnosis of an AMI, and subsequently transferred to a different 
hospital where an alternative principal diagnosis may be assigned if appropriate.   
 
In-hospital mortality rate within 30 days after stroke 
There was a relatively low volume of transfers of cases within the ischaemic stroke indicator. Less 
than 3% of cases with ischaemic stroke had a source of admission indicating a transfer in from 
another hospital.  
A higher proportion of cases within the haemorrhagic stroke indicator were transferred.  27% of cases 
had a source of admission indicating a transfer in.  
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In-hospital mortality rate within 30 days after hip fracture surgery 
Approximately 11% of cases within this indicator had a source of admission indicating a transfer in. 
96% of these transfers were recorded as emergencies, and the remaining 4% were elective transfers. 
Given that for cases to be included in this indicator they were required to have both a principal 
diagnosis of a hip fracture, and a principal procedure related to the repair of the hip fracture, the issue 
of counting cases in more than one hospital does not arise. It is likely that each patient is only having 
surgery for the hip fracture in one hospital. Cases that are admitted to one hospital with a hip fracture 
and then transferred to a second hospital for surgery would only be counted in the second hospital in 
this indicator. Therefore the transferring of cases between hospitals is unlikely affect the calculation of 
this indicator, although further analysis would be required to assess the full effect.   
 
In-hospital mortality rate within 30 days after colectomy following emergency admission 
The data on colectomy procedures showed a relatively low volume of patients being transferred in or 
out of hospitals with this procedure. Approximately 6% of emergency admissions with a colectomy 
procedure between 2006 and 2010 had been transferred in from another hospital.  Almost 4% of 
cases had a colectomy procedure and were then transferred out to another hospital. Patients who are 
transferred from one hospital to another are unlikely to have surgery in both hospitals. Therefore the 
issue of transfers between hospitals should not substantially impact on the findings for this indicator, 
although further analysis would be required to assess the full effect. 
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Appendix 3: Methodology for Age-standardisation of In-hospital 
Mortality Rates 
The crude death rate per 100 cases for the in-hospital mortality indicators is calculated as the number 
of deaths within 30 days in each hospital with the relevant principal diagnosis and/or procedure, 
divided by the number of cases in each hospital with the relevant principal diagnosis and/or 
procedure, and then multiplied by 100.  
However crude death rates do not take variations in the age profile of patients in different hospitals 
into account, and so both direct and indirect age-standardisation was carried out using SAS. Direct 
standardisation results in age-standardised death rates (ASDRs), which express the number of 
deaths (per 100 cases) that would occur in a hospital if that hospital had the same age structure as 
the national population of admitted patients and the age-specific rates for that hospital applied.   
Direct standardisation has the advantage of producing a hospital mortality rate that can be compared 
to other rates based on the same standard population. It can be possible therefore to compare 
ASDRs in one hospital with the national mortality rate, and also with all other hospitals. However, 
difficulties arise in the use of ASDRs when the population being compared contains only a small 
number of deaths in some or all age-groups. Where the number of deaths is relatively small, the 
chance occurrence of one or two additional deaths can distort the rate significantly. This is a major 
limitation of the direct method of age-standardisation when examining in-hospital mortality rates at 
hospital level as opposed to a national level.  
Indirect standardisation is used as an alternative to the direct method of age-standardisation where 
the study population is small and the age-specific rates are unstable. The indirect method of 
standardisation involves applying the age-specific rates of the national population (i.e. all admitted 
patients with the relevant diagnosis or procedure) to the age distribution of the study population (i.e. 
the admitted patients with the relevant diagnosis or procedure in each hospital), and expressing the 
observed deaths compared to the expected deaths as a ratio (age-standardised mortality ratio, SMR).   
Therefore SMRs express the difference between the observed deaths in a hospital compared to the 
expected deaths if the age-specific death rates of the total cases nationally applied. A ratio that is 
greater than 100 suggests that the hospital experienced a higher number of deaths than expected. A 
ratio of less than 100 suggests that the hospital experienced a lower number of deaths than expected.   
95% confidence intervals for the SMRs are also presented, and these should be considered when 
interpreting the results. If the lower limit of the 95% confidence interval is greater than the national 
rate (i.e. 100) then it can be said that the rate is statistically significantly higher than expected at the 
95% confidence level. Note that if a hospital has a relatively small number of cases, there is more 
uncertainty around the rate. Therefore wide confidence intervals for a particular hospital are as a 
result of the small number of cases. The statistical confidence limits associated with these ratios 
generally do not provide evidence of a significant difference from the national rate. Further 
investigation would need to be carried out in order to determine whether any true variation exists. 
Hospitals with a large number of cases have smaller confidence intervals, as their rates are more 
stable. 
The purpose of SMRs is to compare each hospital with the national rate only, and unlike ASDRs, the 
SMRs among hospitals are not directly comparable as the age structure of each hospital weights the 
age-specific rates differently. Therefore SMRs should not be used to compare one hospital against 
another.   
Both the direct and indirect methods of age-standardisation produced similar results in relation to 
statistical significance. The number of deaths in each 5 year age-group at hospital level was relatively 
small for all of the indicators considered, and so only the indirect method of age-standardisation is 
presented in the hospital level tables in this report. By definition, SMRs always have a ratio of 100 at a 
national level, and so ASDRs are displayed in the 10 year trends graphs which are at national level 
only. This allows for comparison of age-standardised mortality rates at a national level over time.  
The OECD produce age-sex standardised rates based on the total admitted population in the OECD 
countries with the relevant condition aged 45+. While the same principal diagnoses for AMI and stroke 
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were used in this study as are used for the OECD indicators, the data were age standardised 
according to the admitted population in Irish hospitals over the three year period 2008 to 2010.  
Age-sex standardised rates were also considered but a preliminary scoping analysis showed that in 
many cases the numbers were too small for statistical significance. Where the numbers were 
sufficiently large, in general the preliminary analysis suggested that the age-sex standardisation 
produced similar results to the age-standardised rates; however this would require further exploration 
as part of the refinement of these indicators. Therefore for this initial study age-standardised rates 
only are presented.  
In order to calculate the SMRs the following steps are followed (using the example of AMI): 
1. The numbers of deaths and cases of AMI in each hospital (based on the numerator and 
denominator specifications) are reported by 5 year age-groups (15-19, 20-24, etc., up to 85+). 
2. The total number of cases of AMI (based on the denominator specification) for all hospitals 
nationally are reported by the same 5 year age-groups.  
3. The national age-specific mortality rates for each of the 5 year age-groups are calculated, i.e. 
deaths within 30 days in all hospitals divided by cases in all hospitals. 
4. Each of the national age-specific mortality rates is then multiplied by the number of cases within 
that age-group in each hospital, i.e. multiplying the age-specific national rates by the number of 
cases in each hospital to give the ‘expected deaths’ within each age-group if the national age-
specific mortality rates applied. 
5. The age-standardised mortality ratio (SMR) is then calculated as the number of actual (observed) 
deaths in each hospital divided by the sum of the ‘expected deaths’ and then multiplied by 100.  It 
is a ratio of the number of observed deaths compared to the number of deaths that would be 
expected if the national age-specific mortality rates applied. It eliminates any bias in a hospital’s 
mortality rate caused by having younger or older patients than other hospitals. 
6. The upper and lower 95% confidence intervals are then calculated. If the number of observed 
deaths in a hospital is 100 or less, the upper and lower confidence intervals are obtained directly 
from a table of exact confidence limits for a Poisson count using the following formula: 
Lower limit:                    x1/e*100 
Upper limit:                     x2/e*100 
where x1 and x2 are the lower and upper limits respectively for the observed number of deaths 
from the table of exact 95% confidence limits for a Poisson count, and e is the expected number 
of deaths. 
Note that the Poisson distribution is asymmetrical, and so the use of the Poisson count results in 
confidence limits that are not symmetrical around the SMR.   
If the observed number of deaths is over 100, the following formula is used for the confidence 
limits:  
(d  (1.96 * d))/e*100 
where d is the observed  number of deaths and e is the expected number of deaths. 
(Daly LE, Bourke GJ: Interpretation and Uses of Medical Statistics) 
 
 
